WO2021244244A1 - Oxadiazole compound and application thereof - Google Patents

Oxadiazole compound and application thereof Download PDF

Info

Publication number
WO2021244244A1
WO2021244244A1 PCT/CN2021/093237 CN2021093237W WO2021244244A1 WO 2021244244 A1 WO2021244244 A1 WO 2021244244A1 CN 2021093237 W CN2021093237 W CN 2021093237W WO 2021244244 A1 WO2021244244 A1 WO 2021244244A1
Authority
WO
WIPO (PCT)
Prior art keywords
acid
compound
general formula
alkyl
hydrogen
Prior art date
Application number
PCT/CN2021/093237
Other languages
French (fr)
Chinese (zh)
Inventor
张立新
张静
刘梦竹
裴鸿艳
康卓
Original Assignee
沈阳化工大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 沈阳化工大学 filed Critical 沈阳化工大学
Publication of WO2021244244A1 publication Critical patent/WO2021244244A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/82Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with three ring hetero atoms
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N53/00Biocides, pest repellants or attractants, or plant growth regulators containing cyclopropane carboxylic acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P1/00Disinfectants; Antimicrobial compounds or mixtures thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P3/00Fungicides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Disclosed is an oxadiazole compound having a novel structure and as represented by general formula I: a compound of the general formula I has excellent bactericidal activity, and has a good prevention and control effect for plant bacterial diseases and fungal diseases. The present invention comprises uses of the compound of the general formula I as a bactericide in agriculture and other fields.

Description

一种噁二唑类化合物及其应用An oxadiazole compound and its application 技术领域Technical field
本发明属农用杀菌剂领域。具体地涉及一种噁二唑类化合物及其应用。The invention belongs to the field of agricultural fungicides. Specifically, it relates to an oxadiazole compound and its application.
背景技术Background technique
WO2017081309A1,WO2017081310A1,WO2017081311A1,WO2017081312A1,WO2018015449A1,WO2018015458A1,WO2017055469A1,WO2017085098A1,WO2017085100A1,WO2017103219A1及WO2017178245A1等专利涉及3-芳基(杂芳基)-5-三氟甲基噁二唑衍生物及它们在防除植物病原性微生物中的用途。WO2017081309A1, WO2017081310A1, WO2017081311A1, WO2017081312A1, WO2018015449A1, WO2018015458A1, WO2017055469A1, WO2017085098A1, WO2017085100A1, WO2017103219A1 and WO2017178245A1 and other patents related to 3-aryl (heteroaryl) plant derivatives and their derivatives in 3-aryl (heteroaryl) plant derivatives Use in pathogenic microorganisms.
现有技术中,如本发明所示的噁二唑类化合物及其杀菌活性未见报道。In the prior art, the oxadiazole compound and its bactericidal activity as shown in the present invention have not been reported.
发明内容Summary of the invention
本发明的目的是提供一种可以控制多种植物细菌性病害和真菌性病害的噁二唑类化合物,及其用于制备农业和其它领域中防治病菌的药物。The purpose of the present invention is to provide an oxadiazole compound that can control a variety of plant bacterial diseases and fungal diseases, and its use in the preparation of medicines for preventing and controlling pathogens in agriculture and other fields.
为实现上述目的,本发明的技术方案如下:In order to achieve the above objective, the technical solution of the present invention is as follows:
一种噁二唑类化合物,如通式I所示:An oxadiazole compound, as shown in general formula I:
Figure PCTCN2021093237-appb-000001
Figure PCTCN2021093237-appb-000001
式中:Where:
R 1选自氢、羟基、巯基、氨基、氰基、C 1-C 6烷基、卤代C 1-C 6烷基、C 1-C 6烷氧基、卤代C 1-C 6烷氧基、C 1-C 6烷硫基、卤代C 1-C 6烷硫基、C 1-C 6烷基氨基或C 1-C 6二烷基氨基; R 1 is selected from hydrogen, hydroxyl, mercapto, amino, cyano, C 1 -C 6 alkyl, halogenated C 1 -C 6 alkyl, C 1 -C 6 alkoxy, halogenated C 1 -C 6 alkane Oxy, C 1 -C 6 alkylthio, halogenated C 1 -C 6 alkylthio, C 1 -C 6 alkylamino or C 1 -C 6 dialkylamino;
R 2选自氢、C 1-C 6烷基、卤代C 1-C 6烷基、C 1-C 6烷基羰基、C 3-C 6环烷基羰基、C 3-C 6环烷基C 1-C 3烷基羰基、C 1-C 6烷氧基羰基、C 1-C 6烷氧基C 1-C 3烷基羰基、C 1-C 6烷硫基C 1-C 3烷基羰基、C 1-C 6烷基氨基羰基或C 1-C 6二烷基氨基羰基; R 2 is selected from hydrogen, C 1 -C 6 alkyl, halogenated C 1 -C 6 alkyl, C 1 -C 6 alkylcarbonyl, C 3 -C 6 cycloalkylcarbonyl, C 3 -C 6 cycloalkane C 1 -C 3 alkylcarbonyl, C 1 -C 6 alkoxycarbonyl, C 1 -C 6 alkoxy C 1 -C 3 alkylcarbonyl, C 1 -C 6 alkylthio C 1 -C 3 Alkylcarbonyl, C 1 -C 6 alkylaminocarbonyl or C 1 -C 6 dialkylaminocarbonyl;
X 1、X 2各自独立地选自氢、卤素或C 1-C 6烷基; X 1 and X 2 are each independently selected from hydrogen, halogen or C 1 -C 6 alkyl;
n选自0或1;n is selected from 0 or 1;
或通式I化合物的盐。Or a salt of a compound of general formula I.
本发明中较为优选的化合物为:通式I中The more preferred compound in the present invention is: in general formula I
R 1选自氢、羟基、巯基、氨基、氰基、C 1-C 3烷基、卤代C 1-C 3烷基、C 1-C 3烷氧基、卤代C 1-C 3烷氧基、C 1-C 3烷硫基、卤代C 1-C 3烷硫基、C 1-C 3烷基氨基或C 1-C 3二烷基氨基; R 1 is selected from hydrogen, hydroxyl, mercapto, amino, cyano, C 1 -C 3 alkyl, halo C 1 -C 3 alkyl, C 1 -C 3 alkoxy, halo C 1 -C 3 alkane Oxy, C 1 -C 3 alkylthio, halogenated C 1 -C 3 alkylthio, C 1 -C 3 alkylamino or C 1 -C 3 dialkylamino;
R 2选自氢、C 1-C 4烷基、卤代C 1-C 4烷基、C 1-C 4烷基羰基、C 3-C 4环烷基羰基、C 3-C 4环烷基 C 1-C 2烷基羰基、C 1-C 4烷氧基羰基、C 1-C 4烷氧基C 1-C 2烷基羰基、C 1-C 4烷硫基C 1-C 2烷基羰基、C 1-C 4烷基氨基羰基或C 1-C 4二烷基氨基羰基; R 2 is selected from hydrogen, C 1 -C 4 alkyl, halogenated C 1 -C 4 alkyl, C 1 -C 4 alkylcarbonyl, C 3 -C 4 cycloalkylcarbonyl, C 3 -C 4 cycloalkane C 1 -C 2 alkylcarbonyl, C 1 -C 4 alkoxycarbonyl, C 1 -C 4 alkoxy C 1 -C 2 alkylcarbonyl, C 1 -C 4 alkylthio C 1 -C 2 Alkylcarbonyl, C 1 -C 4 alkylaminocarbonyl or C 1 -C 4 dialkylaminocarbonyl;
X 1、X 2各自独立地选自氢、氟或甲基; X 1 and X 2 are each independently selected from hydrogen, fluorine or methyl;
n选自0或1;n is selected from 0 or 1;
或通式I化合物与盐酸、氢溴酸、硫酸、磷酸、甲酸、乙酸、丙酸、丁酸、戊酸、三氟乙酸、草酸、丙二酸、甲磺酸、4-甲苯磺酸、苹果酸、富马酸、乳酸、马来酸、水杨酸、酒石酸或柠檬酸形成的盐。Or compound of general formula I and hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, formic acid, acetic acid, propionic acid, butyric acid, valeric acid, trifluoroacetic acid, oxalic acid, malonic acid, methanesulfonic acid, 4-toluenesulfonic acid, apple Salts of acid, fumaric acid, lactic acid, maleic acid, salicylic acid, tartaric acid or citric acid.
本发明进一步优选的化合物为:通式I中A further preferred compound of the present invention is: in general formula I
R 1选自氢、羟基、巯基、氨基、氰基、C 1-C 3烷基、卤代C 1-C 3烷基、C 1-C 3烷氧基、卤代C 1-C 3烷氧基、C 1-C 3烷硫基、卤代C 1-C 3烷硫基、C 1-C 3烷基氨基或C 1-C 3二烷基氨基; R 1 is selected from hydrogen, hydroxyl, mercapto, amino, cyano, C 1 -C 3 alkyl, halo C 1 -C 3 alkyl, C 1 -C 3 alkoxy, halo C 1 -C 3 alkane Oxy, C 1 -C 3 alkylthio, halogenated C 1 -C 3 alkylthio, C 1 -C 3 alkylamino or C 1 -C 3 dialkylamino;
R 2选自氢、C 1-C 4烷基、卤代C 1-C 4烷基、C 1-C 4烷基羰基、C 3-C 4环烷基羰基、2-(C 3-C 4环烷基)乙酰基、C 1-C 4烷氧基羰基、2-(C 1-C 4烷氧基)乙酰基、2-(C 1-C 4烷硫基)乙酰基、C 1-C 4烷基氨基羰基或C 1-C 4二烷基氨基羰基; R 2 is selected from hydrogen, C 1 -C 4 alkyl, halogenated C 1 -C 4 alkyl, C 1 -C 4 alkylcarbonyl, C 3 -C 4 cycloalkylcarbonyl, 2-(C 3 -C 4 cycloalkyl) acetyl, C 1 -C 4 alkoxycarbonyl, 2-(C 1 -C 4 alkoxy)acetyl, 2-(C 1 -C 4 alkylthio)acetyl, C 1 -C 4 alkylaminocarbonyl or C 1 -C 4 dialkylaminocarbonyl;
X 1、X 2选自氢、氟或甲基; X 1 and X 2 are selected from hydrogen, fluorine or methyl;
n选自0或1;n is selected from 0 or 1;
或通式I化合物与盐酸、氢溴酸、硫酸、磷酸、甲酸、乙酸、丙酸、丁酸、戊酸、三氟乙酸、草酸、丙二酸、甲磺酸、4-甲苯磺酸、苹果酸、富马酸、乳酸、马来酸、水杨酸、酒石酸或柠檬酸形成的盐。Or compound of general formula I and hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, formic acid, acetic acid, propionic acid, butyric acid, valeric acid, trifluoroacetic acid, oxalic acid, malonic acid, methanesulfonic acid, 4-toluenesulfonic acid, apple Salts of acid, fumaric acid, lactic acid, maleic acid, salicylic acid, tartaric acid or citric acid.
本发明更进一步优选的化合物为:通式I中A further preferred compound of the present invention is: in the general formula I
R 1选自氢、氨基、C 1-C 3烷基、C 1-C 3烷氧基或C 1-C 3烷硫基; R 1 is selected from hydrogen, amino, C 1 -C 3 alkyl, C 1 -C 3 alkoxy or C 1 -C 3 alkylthio;
R 2选自氢、C 1-C 4烷基、卤代C 1-C 4烷基、C 1-C 4烷基羰基、C 3-C 4环烷基羰基、2-(C 3-C 4环烷基)乙酰基、2-(C 1-C 4烷氧基)乙酰基或C 1-C 4二烷基氨基羰基; R 2 is selected from hydrogen, C 1 -C 4 alkyl, halogenated C 1 -C 4 alkyl, C 1 -C 4 alkylcarbonyl, C 3 -C 4 cycloalkylcarbonyl, 2-(C 3 -C 4 -cycloalkyl)acetyl, 2-(C 1 -C 4 alkoxy)acetyl or C 1 -C 4 dialkylaminocarbonyl;
X 1、X 2选自氢; X 1 and X 2 are selected from hydrogen;
n选自0或1;n is selected from 0 or 1;
或通式I化合物与盐酸、氢溴酸、硫酸、磷酸、甲酸、乙酸、丙酸、丁酸、戊酸、三氟乙酸、草酸、丙二酸、甲磺酸、4-甲苯磺酸、苹果酸、富马酸、乳酸、马来酸、水杨酸、酒石酸或柠檬酸形成的盐。Or compound of general formula I and hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, formic acid, acetic acid, propionic acid, butyric acid, valeric acid, trifluoroacetic acid, oxalic acid, malonic acid, methanesulfonic acid, 4-toluenesulfonic acid, apple Salts of acid, fumaric acid, lactic acid, maleic acid, salicylic acid, tartaric acid or citric acid.
或者,本发明更进一步优选的化合物为:通式I中Alternatively, a further preferred compound of the present invention is: in general formula I
R 1选自氢、羟基、巯基、氨基、氰基、甲基、乙基、正丙基、异丙基、三氟甲基、甲氧基、乙氧基、二氟甲氧基、三氟甲氧基、甲硫基、乙硫基、三氟乙硫基、甲氨基、乙氨基或N,N-二甲基氨基; R 1 is selected from hydrogen, hydroxyl, mercapto, amino, cyano, methyl, ethyl, n-propyl, isopropyl, trifluoromethyl, methoxy, ethoxy, difluoromethoxy, trifluoro Methoxy, methylthio, ethylthio, trifluoroethylthio, methylamino, ethylamino or N,N-dimethylamino;
R 2选自氢、甲基、乙基、正丙基、异丙基、正丁基、异丁基、仲丁基、叔丁基、三氟甲基、乙酰基、丙酰基、正丁酰基、异丁酰基、正戊酰基、环丙基羰基、1-氰基环丙基-1-羰基、环丁基羰基、2-环丙基乙酰基、甲氧基羰基、乙氧基羰基、2-甲氧基乙酰基、2-乙氧基乙酰基、2-正丙氧基乙酰基、2-异丙氧基乙酰基、2-正丁氧基乙酰基、2-仲丁氧基乙酰基、2-异丁氧基乙酰基、2-叔丁氧基乙酰基、2-甲硫基乙酰基、2-乙硫基乙酰基、N-甲基氨基羰基、N-乙基氨基羰基或N,N-二甲基氨基羰基; R 2 is selected from hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, trifluoromethyl, acetyl, propionyl, n-butyryl , Isobutyryl, n-valeryl, cyclopropylcarbonyl, 1-cyanocyclopropyl-1-carbonyl, cyclobutylcarbonyl, 2-cyclopropylacetyl, methoxycarbonyl, ethoxycarbonyl, 2 -Methoxyacetyl, 2-ethoxyacetyl, 2-n-propoxyacetyl, 2-isopropoxyacetyl, 2-n-butoxyacetyl, 2-sec-butoxyacetyl , 2-isobutoxyacetyl, 2-tert-butoxyacetyl, 2-methylthioacetyl, 2-ethylthioacetyl, N-methylaminocarbonyl, N-ethylaminocarbonyl or N ,N-Dimethylaminocarbonyl;
X 1、X 2选自氢、氟或甲基; X 1 and X 2 are selected from hydrogen, fluorine or methyl;
n选自0或1;n is selected from 0 or 1;
或通式I化合物与盐酸、氢溴酸、硫酸、磷酸、甲酸、乙酸、丙酸、丁酸、戊酸、三氟乙酸、草酸、丙二酸、甲磺酸、4-甲苯磺酸、苹果酸、富马酸、乳酸、马来酸、水杨酸、酒石酸或柠檬酸形成的盐。Or compound of general formula I and hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, formic acid, acetic acid, propionic acid, butyric acid, valeric acid, trifluoroacetic acid, oxalic acid, malonic acid, methanesulfonic acid, 4-toluenesulfonic acid, apple Salts of acid, fumaric acid, lactic acid, maleic acid, salicylic acid, tartaric acid or citric acid.
本发明再一步优选的化合物为:通式I中A further preferred compound of the present invention is: in general formula I
R 1选自氢; R 1 is selected from hydrogen;
R 2选自氢、C 1-C 4烷基、卤代C 1-C 4烷基、C 1-C 4烷基羰基、C 3-C 4环烷基羰基、2-(C 3-C 4环烷基)乙酰基、2-(C 1-C 4烷氧基)乙酰基或C 1-C 4二烷基氨基羰基; R 2 is selected from hydrogen, C 1 -C 4 alkyl, halogenated C 1 -C 4 alkyl, C 1 -C 4 alkylcarbonyl, C 3 -C 4 cycloalkylcarbonyl, 2-(C 3 -C 4 -cycloalkyl)acetyl, 2-(C 1 -C 4 alkoxy)acetyl or C 1 -C 4 dialkylaminocarbonyl;
X 1、X 2选自氢; X 1 and X 2 are selected from hydrogen;
n选自0或1;n is selected from 0 or 1;
或通式I化合物与盐酸、氢溴酸、硫酸、磷酸、甲酸、乙酸、丙酸、丁酸、戊酸、三氟乙酸、草酸、丙二酸、甲磺酸、4-甲苯磺酸、苹果酸、富马酸、乳酸、马来酸、水杨酸、酒石酸或柠檬酸形成的盐。Or compound of general formula I and hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, formic acid, acetic acid, propionic acid, butyric acid, valeric acid, trifluoroacetic acid, oxalic acid, malonic acid, methanesulfonic acid, 4-toluenesulfonic acid, apple Salts of acid, fumaric acid, lactic acid, maleic acid, salicylic acid, tartaric acid or citric acid.
或者,本发明再一步优选的化合物为:通式I中Alternatively, a further preferred compound of the present invention is: in general formula I
R 1选自氢、氨基、C 1-C 3烷基或C 1-C 3烷硫基; R 1 is selected from hydrogen, amino, C 1 -C 3 alkyl or C 1 -C 3 alkylthio;
R 2选自氢、C 1-C 4烷基、卤代C 1-C 4烷基、C 1-C 4烷基羰基、C 3-C 4环烷基羰基、2-(C 3-C 4环烷基)乙酰基、2-(C 1-C 4烷氧基)乙酰基或C 1-C 4二烷基氨基羰基; R 2 is selected from hydrogen, C 1 -C 4 alkyl, halogenated C 1 -C 4 alkyl, C 1 -C 4 alkylcarbonyl, C 3 -C 4 cycloalkylcarbonyl, 2-(C 3 -C 4 -cycloalkyl)acetyl, 2-(C 1 -C 4 alkoxy)acetyl or C 1 -C 4 dialkylaminocarbonyl;
X 1、X 2选自氢; X 1 and X 2 are selected from hydrogen;
n选自1;n is selected from 1;
或通式I化合物与盐酸、氢溴酸、硫酸、磷酸、甲酸、乙酸、丙酸、丁酸、戊酸、三氟乙酸、草酸、丙二酸、甲磺酸、4-甲苯磺酸、苹果酸、富马酸、乳酸、马来酸、水杨酸、酒石酸或柠檬酸形成的盐。Or compound of general formula I and hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, formic acid, acetic acid, propionic acid, butyric acid, valeric acid, trifluoroacetic acid, oxalic acid, malonic acid, methanesulfonic acid, 4-toluenesulfonic acid, apple Salts of acid, fumaric acid, lactic acid, maleic acid, salicylic acid, tartaric acid or citric acid.
本发明再更一步优选的化合物为:通式I中A further preferred compound of the present invention is: in general formula I
R 1选自氢; R 1 is selected from hydrogen;
R 2选自氢、C 1-C 4烷基、卤代C 1-C 4烷基、C 1-C 4烷基羰基、C 3-C 4环烷基羰基、2-(C 3-C 4环烷基)乙酰基、2-(C 1-C 4烷氧基)乙酰基或C 1-C 4二烷基氨基羰基; R 2 is selected from hydrogen, C 1 -C 4 alkyl, halogenated C 1 -C 4 alkyl, C 1 -C 4 alkylcarbonyl, C 3 -C 4 cycloalkylcarbonyl, 2-(C 3 -C 4 -cycloalkyl)acetyl, 2-(C 1 -C 4 alkoxy)acetyl or C 1 -C 4 dialkylaminocarbonyl;
X 1、X 2选自氢; X 1 and X 2 are selected from hydrogen;
n选自0;n is selected from 0;
或通式I化合物与盐酸、氢溴酸、硫酸、磷酸、甲酸、乙酸、丙酸、丁酸、戊酸、三氟乙酸、草酸、丙二酸、甲磺酸、4-甲苯磺酸、苹果酸、富马酸、乳酸、马来酸、水杨酸、酒石酸或柠檬酸形成的盐。Or compound of general formula I and hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, formic acid, acetic acid, propionic acid, butyric acid, valeric acid, trifluoroacetic acid, oxalic acid, malonic acid, methanesulfonic acid, 4-toluenesulfonic acid, apple Salts of acid, fumaric acid, lactic acid, maleic acid, salicylic acid, tartaric acid or citric acid.
上面给出的通式化合物的定义中,汇集所用术语一般代表如下取代基:In the definitions of compounds of the general formula given above, the terms used in pooling generally represent the following substituents:
卤素:指氟、氯、溴或碘。Halogen: Refers to fluorine, chlorine, bromine or iodine.
烷基:直链或支链烷基,例如甲基、乙基、正丙基、异丙基或不同的丁基、戊基或己基异构体。Alkyl: straight or branched chain alkyl, such as methyl, ethyl, n-propyl, isopropyl or different butyl, pentyl or hexyl isomers.
环烷基:指取代或未取代的环状烷基,例如环丙基、环戊基或环己基;取代基如甲基、卤素等。Cycloalkyl: refers to a substituted or unsubstituted cyclic alkyl group, such as cyclopropyl, cyclopentyl or cyclohexyl; substituents such as methyl, halogen and the like.
卤代烷基:直链或支链烷基,在这些烷基上的氢原子可部分或全部被卤素所取代,例如氯甲基、二氯甲基、三氯甲基、氟甲基、二氟甲基、三氟甲基、2,2,2-三氟乙基、七氟异丙基、1,1,2,2,2-五氟乙基等。Halogenated alkyl groups: straight or branched chain alkyl groups. The hydrogen atoms on these alkyl groups can be partially or completely replaced by halogens, such as chloromethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl Group, trifluoromethyl, 2,2,2-trifluoroethyl, heptafluoroisopropyl, 1,1,2,2,2-pentafluoroethyl, etc.
烷氧基:直链或支链烷基,经氧原子键连接到结构上,例如甲氧基、乙氧基、叔丁氧基等。Alkoxy: straight or branched chain alkyl, connected to the structure via an oxygen atom bond, such as methoxy, ethoxy, tert-butoxy, etc.
卤代烷氧基:烷氧基上的氢原子可部分或全部被卤素所取代,例如氯甲氧基、二氯甲氧基、三氯甲氧基、氟甲氧基、二氟甲氧基、三氟甲氧基、氯氟甲氧基、三氟乙氧基等。Haloalkoxy: The hydrogen atoms on the alkoxy group can be partially or completely replaced by halogen, such as chloromethoxy, dichloromethoxy, trichloromethoxy, fluoromethoxy, difluoromethoxy, tri Fluoromethoxy, chlorofluoromethoxy, trifluoroethoxy and the like.
烷硫基:直链或支链烷基,经硫原子键连接到结构上,例如甲硫基、乙硫基等。Alkylthio: straight or branched chain alkyl, connected to the structure via a sulfur atom bond, such as methylthio, ethylthio and the like.
卤代烷硫基:烷硫基上的氢原子可部分或全部被卤素所取代,例如二氟甲硫基、三氟乙硫基等。Haloalkylthio: The hydrogen atoms on the alkylthio group can be partially or completely replaced by halogen, such as difluoromethylthio, trifluoroethylthio and the like.
烷基氨基:直链或支链烷基,经氮原子键连接到结构上,例如甲氨基(CH 3NH-)、乙氨基(CH 3CH 2NH-)、正丙基氨基(CH 3CH 2CH 2NH-)、异丙基氨基((CH 3) 2CHNH-)或同分异构的丁基胺。 Alkylamino: straight or branched chain alkyl, connected to the structure via a nitrogen atom bond, such as methylamino (CH 3 NH-), ethylamino (CH 3 CH 2 NH-), n-propylamino (CH 3 CH 2 CH 2 NH-), isopropylamino ((CH 3 ) 2 CHNH-) or isomeric butylamine.
二烷基氨基:两个相同或不同的直链或支链烷基,经氮原子键连接到结构上,例如二甲基氨基((CH 3) 2N-)、甲基乙基氨基((CH 3)(CH 3CH 2)N-)等。 Dialkylamino: Two identical or different linear or branched alkyl groups are connected to the structure via a nitrogen atom bond, such as dimethylamino ((CH 3 ) 2 N-), methylethylamino (( CH 3 )(CH 3 CH 2 )N-) and so on.
烷基羰基:烷基-CO-,例如乙酰基(CH 3CO-)、丙酰基(CH 3CH 2CO-)、正丁酰基(CH 3CH 2CH 2CO-)、异丁酰基((CH 3) 2CHCO-)、正戊酰基(CH 3CH 2CH 2CH 2CO-)等。 Alkylcarbonyl: alkyl-CO-, such as acetyl (CH 3 CO-), propionyl (CH 3 CH 2 CO-), n-butyryl (CH 3 CH 2 CH 2 CO-), isobutyryl (( CH 3 ) 2 CHCO-), n-valeryl (CH 3 CH 2 CH 2 CH 2 CO-), etc.
环烷基羰基:环烷基-CO-,例如环丙基羰基
Figure PCTCN2021093237-appb-000002
1-氰基环丙基-1-羰基
Figure PCTCN2021093237-appb-000003
环丁基羰基
Figure PCTCN2021093237-appb-000004
等。
Cycloalkylcarbonyl: cycloalkyl-CO-, such as cyclopropylcarbonyl
Figure PCTCN2021093237-appb-000002
1-cyanocyclopropyl-1-carbonyl
Figure PCTCN2021093237-appb-000003
Cyclobutyl carbonyl
Figure PCTCN2021093237-appb-000004
Wait.
环烷基烷基羰基:环烷基-烷基-CO-,例如2-(C 3-C 4环烷基)乙酰基,更具体地,例如2-环丙基乙酰基
Figure PCTCN2021093237-appb-000005
等。
Cycloalkylalkyl-carbonyl group: a cycloalkyl group - CO- group, for example, 2- (C 3 -C 4 cycloalkyl) acetyl, more specifically, for example, 2-cyclopropyl-acetyl
Figure PCTCN2021093237-appb-000005
Wait.
烷氧基羰基:烷基-O-CO-,例如甲氧基羰基(CH 3OCO-)、乙氧基羰基(CH 3CH 2OCO-)等。 Alkoxycarbonyl: alkyl-O-CO-, such as methoxycarbonyl (CH 3 OCO-), ethoxycarbonyl (CH 3 CH 2 OCO-) and the like.
烷氧基烷基羰基:烷氧基-烷基-CO-,例如2-(C 1-C 4烷氧基)乙酰基,更具体地,例如2-甲氧基乙酰基
Figure PCTCN2021093237-appb-000006
2-乙氧基乙酰基
Figure PCTCN2021093237-appb-000007
2-正丙氧基乙酰基
Figure PCTCN2021093237-appb-000008
2-异丙氧基乙酰基
Figure PCTCN2021093237-appb-000009
2-正丁氧基乙酰基
Figure PCTCN2021093237-appb-000010
2-仲丁氧基乙酰基
Figure PCTCN2021093237-appb-000011
2-异丁氧基乙酰基
Figure PCTCN2021093237-appb-000012
2-叔丁氧基乙酰基
Figure PCTCN2021093237-appb-000013
等。
Alkoxyalkylcarbonyl: alkoxy-alkyl-CO-, such as 2-(C 1 -C 4 alkoxy)acetyl, more specifically, such as 2-methoxyacetyl
Figure PCTCN2021093237-appb-000006
2-ethoxyacetyl
Figure PCTCN2021093237-appb-000007
2-n-propoxy acetyl
Figure PCTCN2021093237-appb-000008
2-isopropoxyacetyl
Figure PCTCN2021093237-appb-000009
2-n-butoxy acetyl
Figure PCTCN2021093237-appb-000010
2-sec-butoxyacetyl
Figure PCTCN2021093237-appb-000011
2-isobutoxyacetyl
Figure PCTCN2021093237-appb-000012
2-tert-Butoxyacetyl
Figure PCTCN2021093237-appb-000013
Wait.
烷硫基烷基羰基:烷硫基-烷基-CO-,例如2-(C 1-C 4烷硫基)乙酰基,更具体地,例如2-甲硫基乙酰基
Figure PCTCN2021093237-appb-000014
2-乙硫基乙酰基
Figure PCTCN2021093237-appb-000015
等。
Alkylthioalkylcarbonyl: alkylthio-alkyl-CO-, for example 2-(C 1 -C 4 alkylthio)acetyl, more specifically, for example 2-methylthioacetyl
Figure PCTCN2021093237-appb-000014
2-Ethylthioacetyl
Figure PCTCN2021093237-appb-000015
Wait.
烷基氨基羰基:烷基-NH-CO-,例如N-甲基氨基羰基(CH 3NHCO-),N-乙基氨基羰基(CH3CH2NHCO-)等。 Alkylaminocarbonyl: alkyl-NH-CO-, such as N-methylaminocarbonyl (CH 3 NHCO-), N-ethylaminocarbonyl (CH3CH2NHCO-) and the like.
二烷基氨基羰基:例如N,N-二甲基氨基羰基((CH3)2NCO-),N,N-二乙基氨基羰基((CH3CH2)2NCO-)。Dialkylaminocarbonyl: for example, N,N-dimethylaminocarbonyl ((CH3)2NCO-), N,N-diethylaminocarbonyl ((CH3CH2)2NCO-).
本发明部分通式I化合物如表1所示,但本发明绝非仅限于这些化合物。Some of the compounds of general formula I of the present invention are shown in Table 1, but the present invention is by no means limited to these compounds.
Figure PCTCN2021093237-appb-000016
Figure PCTCN2021093237-appb-000016
Figure PCTCN2021093237-appb-000017
Figure PCTCN2021093237-appb-000017
Figure PCTCN2021093237-appb-000018
Figure PCTCN2021093237-appb-000018
Figure PCTCN2021093237-appb-000019
Figure PCTCN2021093237-appb-000019
Figure PCTCN2021093237-appb-000020
Figure PCTCN2021093237-appb-000020
Figure PCTCN2021093237-appb-000021
Figure PCTCN2021093237-appb-000021
Figure PCTCN2021093237-appb-000022
Figure PCTCN2021093237-appb-000022
本发明的通式I化合物可按照以下方法制备(式中各基团除另有说明外定义同前):方法1:当R 1为氢、C 1-C 6烷基或卤代C 1-C 6烷基时,通式I化合物可按以下方法进行制备(L表示C 1-C 6烷氧基,如甲氧基、乙氧基等): The compound of general formula I of the present invention can be prepared according to the following method (each group in the formula is defined as before unless otherwise specified): Method 1: When R 1 is hydrogen, C 1 -C 6 alkyl or halogenated C 1- In the case of C 6 alkyl, the compound of general formula I can be prepared as follows (L represents C 1 -C 6 alkoxy, such as methoxy, ethoxy, etc.):
Figure PCTCN2021093237-appb-000023
Figure PCTCN2021093237-appb-000023
通式II-1化合物或通式II-2化合物与通式III-1化合物在适宜的溶剂中,在温度从-10℃到溶剂沸点下反应0.5-48小时可制得通式I-1化合物;反应可在碱存在进行。A compound of general formula II-1 or a compound of general formula II-2 and a compound of general formula III-1 are reacted in a suitable solvent at a temperature from -10°C to the boiling point of the solvent for 0.5-48 hours to prepare a compound of general formula I-1 ; The reaction can be carried out in the presence of a base.
通式I-1化合物与酰基化试剂(如乙酰氯、丙酰氯、正丁酰氯、异丁酰氯、正戊酰氯、 环丙基甲酰氯、1-氰基环丙基-1-甲酰氯、环丁基甲酰氯、2-环丙基乙酰氯、氯甲酸甲酯、氯甲酸乙酯、2-甲氧基乙酰氯、2-乙氧基乙酰氯、2-正丙氧基乙酰氯、2-异丙氧基乙酰氯、2-正丁氧基乙酰氯、2-仲丁氧基乙酰氯、2-异丁氧基乙酰氯、2-叔丁氧基乙酰氯、2-甲硫基乙酰氯、2-乙硫基乙酰氯、N-甲基氨基甲酰氯、N-乙基氨基甲酰氯或N,N-二甲基氨基甲酰氯等)或烷基化试剂(如碘甲烷、碘乙烷、碘丙烷、硫酸二甲酯、硫酸二乙酯、2,2,2-三氟碘乙烷等)在适宜的溶剂中,在温度从-10℃到溶剂沸点下反应0.5-48小时可制得通式I-2化合物;反应可在碱存在进行。Compounds of general formula I-1 and acylating reagents (such as acetyl chloride, propionyl chloride, n-butyryl chloride, isobutyryl chloride, n-valeryl chloride, cyclopropylformyl chloride, 1-cyanocyclopropyl-1-formyl chloride, ring Butylformyl chloride, 2-cyclopropylacetyl chloride, methyl chloroformate, ethyl chloroformate, 2-methoxyacetyl chloride, 2-ethoxyacetyl chloride, 2-n-propoxyacetyl chloride, 2-isopropyl Oxyacetyl chloride, 2-n-butoxy acetyl chloride, 2-sec-butoxy acetyl chloride, 2-isobutoxy acetyl chloride, 2-tert-butoxy acetyl chloride, 2-methylthio acetyl chloride, 2 -Ethylthioacetyl chloride, N-methylcarbamoyl chloride, N-ethylcarbamoyl chloride or N,N-dimethylcarbamoyl chloride, etc.) or alkylating reagents (such as methyl iodide, ethyl iodide, iodine) Propane, dimethyl sulfate, diethyl sulfate, 2,2,2-trifluoroiodoethane, etc.) can be prepared by reacting in a suitable solvent at a temperature from -10°C to the boiling point of the solvent for 0.5-48 hours. Compound of formula I-2; the reaction can be carried out in the presence of a base.
上述反应中,适宜的溶剂可相同或不同,可为醇类(如,甲醇、乙醇等)、芳烃类(如,苯、甲苯、二甲苯等)、酮类(如,丙酮、甲乙酮、甲基异丁基酮等)、卤代烃类(如,氯仿、二氯甲烷等)、酯类(如,乙酸甲酯、乙酸乙酯等)、醚类(如,四氢呋喃、二噁烷、二乙醚、1,2-二甲氧基乙烷等)、极性溶剂类(如,水、乙腈、二氧六环、N,N-二甲基甲酰胺、N-甲基吡咯烷酮、二甲基亚砜等)或上述溶剂的混合溶剂。碱可相同或不同,可为三甲胺、三乙胺、吡啶、DBU、4-二甲氨基吡啶等有机碱(如,三甲胺、三乙胺、吡啶、DBU、4-二甲氨基吡啶等)、碱金属氢化物(如,氢化钠、氢化钾等)、碱金属氢氧化物(如,氢氧化钠、氢氧化钾等)、碱土类金属氢氧化物(如,氢氧化钙等)、碱金属碳酸盐(如,碳酸钠、碳酸钾等)、碱金属碳酸氢盐(如,碳酸氢钠等)、金属醇盐(如,甲醇钠、乙醇钠、乙醇钾、叔丁醇钾、叔丁醇钠等)。In the above reaction, suitable solvents can be the same or different, and can be alcohols (e.g., methanol, ethanol, etc.), aromatic hydrocarbons (e.g., benzene, toluene, xylene, etc.), ketones (e.g., acetone, methyl ethyl ketone, methyl Isobutyl ketone, etc.), halogenated hydrocarbons (e.g., chloroform, dichloromethane, etc.), esters (e.g., methyl acetate, ethyl acetate, etc.), ethers (e.g., tetrahydrofuran, dioxane, diethyl ether) , 1,2-dimethoxyethane, etc.), polar solvents (e.g., water, acetonitrile, dioxane, N,N-dimethylformamide, N-methylpyrrolidone, dimethylmethylene Sulfone, etc.) or a mixed solvent of the above solvents. The bases can be the same or different, and can be organic bases such as trimethylamine, triethylamine, pyridine, DBU, 4-dimethylaminopyridine (eg, trimethylamine, triethylamine, pyridine, DBU, 4-dimethylaminopyridine, etc.) , Alkali metal hydrides (e.g., sodium hydride, potassium hydride, etc.), alkali metal hydroxides (e.g., sodium hydroxide, potassium hydroxide, etc.), alkaline earth metal hydroxides (e.g., calcium hydroxide, etc.), alkali Metal carbonates (such as sodium carbonate, potassium carbonate, etc.), alkali metal bicarbonates (such as sodium bicarbonate, etc.), metal alkoxides (such as sodium methoxide, sodium ethoxide, potassium ethoxide, potassium tert-butoxide, tertiary Sodium butoxide, etc.).
方法2:当R 1为C 1-C 6烷硫基或卤代C 1-C 6烷硫基时,通式I化合物可按以下方法进行制备(A表示C 1-C 6烷基或卤代C 1-C 6烷基): Method 2: When R 1 is C 1 -C 6 alkylthio or halogenated C 1 -C 6 alkylthio, the compound of general formula I can be prepared according to the following method (A represents C 1 -C 6 alkyl or halogen Substitute C 1 -C 6 alkyl):
Figure PCTCN2021093237-appb-000024
Figure PCTCN2021093237-appb-000024
通式II-1化合物或通式II-2化合物与通式III-2化合物在适宜的溶剂中,在温度从-10℃到溶剂沸点下反应0.5-48小时可制得通式I-3化合物;反应可在碱存在进行。A compound of general formula II-1 or a compound of general formula II-2 and a compound of general formula III-2 are reacted in a suitable solvent at a temperature from -10°C to the boiling point of the solvent for 0.5-48 hours to prepare a compound of general formula I-3 ; The reaction can be carried out in the presence of a base.
上述反应中,适宜的溶剂可相同或不同,可为醇类(如,甲醇、乙醇等)、芳烃类(如, 苯、甲苯、二甲苯等)、酮类(如,丙酮、甲乙酮、甲基异丁基酮等)、卤代烃类(如,氯仿、二氯甲烷等)、酯类(如,乙酸甲酯、乙酸乙酯等)、醚类(如,四氢呋喃、二噁烷、二乙醚、1,2-二甲氧基乙烷等)、极性溶剂类(如,水、乙腈、二氧六环、N,N-二甲基甲酰胺、N-甲基吡咯烷酮、二甲基亚砜等)或上述溶剂的混合溶剂。碱可相同或不同,可为三甲胺、三乙胺、吡啶、DBU、4-二甲氨基吡啶等有机碱(如,三甲胺、三乙胺、吡啶、DBU、4-二甲氨基吡啶等)、碱金属氢化物(如,氢化钠、氢化钾等)、碱金属氢氧化物(如,氢氧化钠、氢氧化钾等)、碱土类金属氢氧化物(如,氢氧化钙等)、碱金属碳酸盐(如,碳酸钠、碳酸钾等)、碱金属碳酸氢盐(如,碳酸氢钠等)、金属醇盐(如,甲醇钠、乙醇钠、乙醇钾、叔丁醇钾、叔丁醇钠等)。In the above reaction, suitable solvents can be the same or different, and can be alcohols (e.g., methanol, ethanol, etc.), aromatic hydrocarbons (e.g., benzene, toluene, xylene, etc.), and ketones (e.g., acetone, methyl ethyl ketone, methyl ethyl ketone, etc.). Isobutyl ketone, etc.), halogenated hydrocarbons (e.g., chloroform, dichloromethane, etc.), esters (e.g., methyl acetate, ethyl acetate, etc.), ethers (e.g., tetrahydrofuran, dioxane, diethyl ether) , 1,2-dimethoxyethane, etc.), polar solvents (e.g., water, acetonitrile, dioxane, N,N-dimethylformamide, N-methylpyrrolidone, dimethylmethylene Sulfone, etc.) or a mixed solvent of the above solvents. The base can be the same or different, and can be trimethylamine, triethylamine, pyridine, DBU, 4-dimethylaminopyridine and other organic bases (eg, trimethylamine, triethylamine, pyridine, DBU, 4-dimethylaminopyridine, etc.) , Alkali metal hydrides (e.g., sodium hydride, potassium hydride, etc.), alkali metal hydroxides (e.g., sodium hydroxide, potassium hydroxide, etc.), alkaline earth metal hydroxides (e.g., calcium hydroxide, etc.), alkali Metal carbonates (such as sodium carbonate, potassium carbonate, etc.), alkali metal bicarbonates (such as sodium bicarbonate, etc.), metal alkoxides (such as sodium methoxide, sodium ethoxide, potassium ethoxide, potassium tert-butoxide, tertiary Sodium butoxide, etc.).
由通式I-3化合物制备通式I-4化合物的方法与由通式I-1化合物制备通式I-2化合物的方法相同。The method for preparing the compound of the general formula I-4 from the compound of the general formula I-3 is the same as the method for preparing the compound of the general formula I-2 from the compound of the general formula I-1.
方法3:当R 1为羟基、巯基、氨基或C 1-C 6烷基氨基时,通式I化合物可按以下方法进行制备: Method 3: When R 1 is a hydroxyl group, a mercapto group, an amino group or a C 1 -C 6 alkylamino group, the compound of general formula I can be prepared as follows:
Figure PCTCN2021093237-appb-000025
Figure PCTCN2021093237-appb-000025
通式I-3化合物与亲核试剂在适宜的溶剂中,在温度从-10℃到溶剂沸点下反应0.5-48小时可制得通式I-5化合物;通式I-4化合物与亲核试剂在适宜的溶剂中,在温度从-10℃到溶剂沸点下反应0.5-48小时可制得通式I-6化合物。Compounds of general formula I-3 and nucleophiles are reacted in a suitable solvent at a temperature from -10°C to the boiling point of the solvent for 0.5-48 hours to prepare compounds of general formula I-5; compounds of general formula I-4 and nucleophiles The reagents are reacted in a suitable solvent at a temperature from -10°C to the boiling point of the solvent for 0.5-48 hours to prepare a compound of general formula I-6.
Figure PCTCN2021093237-appb-000026
Figure PCTCN2021093237-appb-000026
上述反应中,亲核试剂为氢氧化钠、氢氧化钾、氢氧化锂、硫氢化钠、氨基钠、氨水、C 1-C 6烷基氨(如甲胺、乙胺等)或其盐酸盐(如甲胺盐酸盐、乙胺盐酸盐等)。 In the above reaction, the nucleophile is sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium hydrosulfide, sodium amide, ammonia, C 1 -C 6 alkyl ammonia (such as methylamine, ethylamine, etc.) or its hydrochloric acid Salt (such as methylamine hydrochloride, ethylamine hydrochloride, etc.).
上述反应中,当亲核试剂为C 1-C 6烷基氨盐酸盐时,反应需要适宜的碱参与,以中和盐酸盐,适宜的碱优选三甲胺、三乙胺、吡啶、碳酸钾、碳酸钠、碳酸氢钾、碳酸氢钠等。 In the above reaction, when the nucleophile is C 1 -C 6 alkyl ammonia hydrochloride, the reaction requires the participation of a suitable base to neutralize the hydrochloride. The suitable base is preferably trimethylamine, triethylamine, pyridine, and carbonic acid. Potassium, sodium carbonate, potassium bicarbonate, sodium bicarbonate, etc.
上述反应中,适宜的溶剂可相同或不同,可为醇类(如,甲醇、乙醇等)、芳烃类(如,苯、甲苯、二甲苯等)、酮类(如,丙酮、甲乙酮、甲基异丁基酮等)、卤代烃类(如,氯仿、二氯甲烷等)、酯类(如,乙酸甲酯、乙酸乙酯等)、醚类(如,四氢呋喃、二噁烷、二乙醚、 1,2-二甲氧基乙烷等)、极性溶剂类(如,水、乙腈、二氧六环、N,N-二甲基甲酰胺、N-甲基吡咯烷酮、二甲基亚砜等)或上述溶剂的混合溶剂。In the above reaction, suitable solvents can be the same or different, and can be alcohols (e.g., methanol, ethanol, etc.), aromatic hydrocarbons (e.g., benzene, toluene, xylene, etc.), ketones (e.g., acetone, methyl ethyl ketone, methyl Isobutyl ketone, etc.), halogenated hydrocarbons (e.g., chloroform, dichloromethane, etc.), esters (e.g., methyl acetate, ethyl acetate, etc.), ethers (e.g., tetrahydrofuran, dioxane, diethyl ether) , 1,2-Dimethoxyethane, etc.), polar solvents (e.g., water, acetonitrile, dioxane, N,N-dimethylformamide, N-methylpyrrolidone, dimethylene Sulfone, etc.) or a mixed solvent of the above solvents.
方法4:当R 1为氰基、C 1-C 6烷氧基、卤代C 1-C 6烷氧基或C 1-C 6二烷基氨基时,通式I化合物可按以下方法进行制备: Method 4: When R 1 is a cyano group, a C 1 -C 6 alkoxy group, a halogenated C 1 -C 6 alkoxy group or a C 1 -C 6 dialkylamino group, the compound of general formula I can be carried out as follows preparation:
Figure PCTCN2021093237-appb-000027
Figure PCTCN2021093237-appb-000027
通式I-3化合物与亲核试剂在适宜的溶剂中,在温度从-10℃到溶剂沸点下反应0.5-48小时可制得通式I-7化合物;通式I-4化合物与亲核试剂在适宜的溶剂中,在温度从-10℃到溶剂沸点下反应0.5-48小时可制得通式I-8化合物。The compound of the general formula I-3 and the nucleophile are reacted in a suitable solvent at a temperature from -10°C to the boiling point of the solvent for 0.5-48 hours to obtain the compound of the general formula I-7; the compound of the general formula I-4 and the nucleophilic The reagents are reacted in a suitable solvent at a temperature from -10°C to the boiling point of the solvent for 0.5-48 hours to prepare a compound of general formula I-8.
上述反应中,亲核试剂为氰化钠、氰化钾、C 1-C 6烷醇的碱金属盐(如甲醇钠、甲醇钾、乙醇钠、乙醇钾等)、卤代C 1-C 6烷醇的碱金属盐(如2,2,2-三氟乙醇钠或2,2,2-三氟乙醇钾等)、C 1-C 6二烷基氨(如N,N-二甲基氨、N-甲基-N-乙基氨等)或其盐酸盐(如N,N-二甲基氨盐酸盐、N-甲基-N-乙基氨盐酸盐等)。 In the above reaction, the nucleophile is sodium cyanide, potassium cyanide, alkali metal salts of C 1 -C 6 alkanols (such as sodium methoxide, potassium methoxide, sodium ethoxide, potassium ethoxide, etc.), halogenated C 1 -C 6 Alkali metal salts of alkanols (such as sodium 2,2,2-trifluoroethoxide or potassium 2,2,2-trifluoroethoxide, etc.), C 1 -C 6 dialkyl ammonia (such as N,N-dimethyl Ammonia, N-methyl-N-ethylamine, etc.) or its hydrochloride (such as N,N-dimethylammonium hydrochloride, N-methyl-N-ethylammonium hydrochloride, etc.).
上述反应中,当亲核试剂为C 1-C 6二烷基氨盐酸盐时,反应需要适宜的碱参与,以中和盐酸盐,适宜的碱优选三甲胺、三乙胺、吡啶、碳酸钾、碳酸钠、碳酸氢钾、碳酸氢钠等。 In the above reaction, when the nucleophile is C 1 -C 6 dialkylamine hydrochloride, the reaction requires the participation of a suitable base to neutralize the hydrochloride. Suitable bases are preferably trimethylamine, triethylamine, pyridine, Potassium carbonate, sodium carbonate, potassium bicarbonate, sodium bicarbonate, etc.
上述反应中,适宜的溶剂可相同或不同,可为醇类(如,甲醇、乙醇等)、芳烃类(如,苯、甲苯、二甲苯等)、酮类(如,丙酮、甲乙酮、甲基异丁基酮等)、卤代烃类(如,氯仿、二氯甲烷等)、酯类(如,乙酸甲酯、乙酸乙酯等)、醚类(如,四氢呋喃、二噁烷、二乙醚、1,2-二甲氧基乙烷等)、极性溶剂类(如,水、乙腈、二氧六环、N,N-二甲基甲酰胺、N-甲基吡咯烷酮、二甲基亚砜等)或上述溶剂的混合溶剂。In the above reaction, suitable solvents can be the same or different, and can be alcohols (e.g., methanol, ethanol, etc.), aromatic hydrocarbons (e.g., benzene, toluene, xylene, etc.), ketones (e.g., acetone, methyl ethyl ketone, methyl Isobutyl ketone, etc.), halogenated hydrocarbons (e.g., chloroform, dichloromethane, etc.), esters (e.g., methyl acetate, ethyl acetate, etc.), ethers (e.g., tetrahydrofuran, dioxane, diethyl ether) , 1,2-dimethoxyethane, etc.), polar solvents (e.g., water, acetonitrile, dioxane, N,N-dimethylformamide, N-methylpyrrolidone, dimethylmethylene Sulfone, etc.) or a mixed solvent of the above solvents.
由通式I-7化合物制备通式I-8化合物的方法与由通式I-1化合物制备通式I-2化合物的方法相同。The method for preparing the compound of the general formula I-8 from the compound of the general formula I-7 is the same as the method for preparing the compound of the general formula I-2 from the compound of the general formula I-1.
方法5:当R 2为C 1-C 6烷基或卤代C 1-C 6烷基时,通式I化合物也可按以下方法进行制备: Method 5: When R 2 is a C 1 -C 6 alkyl group or a halogenated C 1 -C 6 alkyl group, the compound of general formula I can also be prepared as follows:
(1)当R 1为氢、C 1-C 6烷基或卤代C 1-C 6烷基时(L表示C 1-C 6烷氧基,如甲氧基、乙氧基 等): (1) When R 1 is hydrogen, C 1 -C 6 alkyl or halo C 1 -C 6 alkyl (L represents C 1 -C 6 alkoxy, such as methoxy, ethoxy, etc.):
Figure PCTCN2021093237-appb-000028
Figure PCTCN2021093237-appb-000028
通式II-3化合物与通式III-1化合物反应可制得通式I-9化合物。由通式II-3化合物制备通式I-9化合物的方法与由通式II-1化合物或通式II-2化合物制备通式I-1化合物的方法相同。The compound of the general formula II-3 can be reacted with the compound of the general formula III-1 to obtain the compound of the general formula I-9. The method for preparing the compound of the general formula I-9 from the compound of the general formula II-3 is the same as the method for preparing the compound of the general formula I-1 from the compound of the general formula II-1 or the compound of the general formula II-2.
(2)当R 1不为氢、C 1-C 6烷基或卤代C 1-C 6烷基时(A表示C 1-C 6烷基或卤代C 1-C 6烷基;K表示羟基、巯基、氨基、氰基、C 1-C 6烷氧基、卤代C 1-C 6烷氧基、C 1-C 6烷基氨基或C 1-C 6二烷基氨基): (2) When R 1 is not hydrogen, C 1 -C 6 alkyl or halo C 1 -C 6 alkyl (A represents C 1 -C 6 alkyl or halo C 1 -C 6 alkyl; K Represents a hydroxyl group, a mercapto group, an amino group, a cyano group, a C 1 -C 6 alkoxy group, a halogenated C 1 -C 6 alkoxy group, a C 1 -C 6 alkylamino group or a C 1 -C 6 dialkylamino group):
Figure PCTCN2021093237-appb-000029
Figure PCTCN2021093237-appb-000029
通式II-3化合物与通式III-2化合物反应可制得通式I-10化合物。由通式II-3化合物制备通式I-10化合物的方法与由通式II-1化合物或通式II-2化合物制备通式I-3化合物的方法相同。The compound of the general formula II-3 can be reacted with the compound of the general formula III-2 to obtain the compound of the general formula I-10. The method for preparing the compound of the general formula I-10 from the compound of the general formula II-3 is the same as the method for preparing the compound of the general formula I-3 from the compound of the general formula II-1 or the compound of the general formula II-2.
通式I-10化合物与亲核试剂反应可制得通式I-11化合物。由通式I-10化合物制备通式I-11化合物与由通式I-4化合物制备通式I-6化合物或由通式I-4化合物制备通式I-8化合物的方法相同。The compound of the general formula I-10 can be prepared by reacting the compound of the general formula I-10 with a nucleophile. The method for preparing the compound of the general formula I-11 from the compound of the general formula I-10 is the same as the method for preparing the compound of the general formula I-6 from the compound of the general formula I-4 or preparing the compound of the general formula I-8 from the compound of the general formula I-4.
上述制备方法中所涉及的原料及中间体来源如下:The sources of raw materials and intermediates involved in the above preparation methods are as follows:
通式II-1化合物可以按公知方法制备,例如参照WO2019171234、WO2018005192、WO2007111212、WO2017081309、WO2018015449或WO2018015458等报道的方法制得;通式II-2化合物可以按公知方法制备,例如参照WO2017018803、WO2018177880、WO2017103219、WO2017109044、WO2017103223、WO2017055469、WO2018185013、WO2018184984或WO2018184987等报道的方法制得;Compounds of general formula II-1 can be prepared according to known methods, for example with reference to the methods reported in WO2019171234, WO2018005192, WO2007111212, WO2017081309, WO2018015449 or WO2018015458; compounds of general formula II-2 can be prepared according to known methods, for example, with reference to WO2017018803, WO2018177880, Prepared by the methods reported in WO2017103219, WO2017109044, WO2017103223, WO2017055469, WO2018185013, WO2018184984 or WO2018184987;
通式II-3化合物可以按公知方法制备,例如参照WO2016031815、WO2018185013、WO2018177894、WO2017055473、WO2017178245或WO2018184988等报道的方法制得;通式III-1化合物可以通过购买或按公知方法制备,例如参照CN105384725、CN108727377、US2503524、WO2004009602、WO2012151525、WO2010060589、WO2005117909、WO2003070729、WO2016196071、WO2016196417、WO2010019637、Bioorganic&Medicinal Chemistry Letters,22(6),2283-2286、ACS Medicinal Chemistry Letters,10(11),1518-1523;2019、 Journal of Medicinal Chemistry,47(24),5894-5911;2004或Journal of Medicinal Chemistry,60(13),5673-5698;2017等报道的方法制得;Compounds of general formula II-3 can be prepared according to known methods, for example, referring to the methods reported in WO2016031815, WO2018185013, WO2018177894, WO2017055473, WO2017178245 or WO2018184988; compounds of general formula III-1 can be prepared by purchase or by known methods, for example, refer to CN105384725 , CN108727377, US2503524, WO2004009602, WO2012151525, WO2010060589, WO2005117909, WO2003070729, WO2016196071, WO2016196417, WO2010019637, Bioorganic&Medicinal Chemistry Letters, 22(6), 2283-2286, ACS Medicinal Chemistry Letters, 2019, 10(11) Journal of Medicinal Chemistry, 47(24), 5894-5911; 2004 or Journal of Medicinal Chemistry, 60(13), 5673-5698; Prepared by the methods reported in 2017;
通式III-2化合物可以通过购买按公知方法制备,例如参照Organic Process Research&Development,15(3),556-564;2011、Molecules,17,12187-12196;2012、Chemical Communications(Cambridge,United Kingdom),53(59),8356-8359;2017、Journal of Enzyme Inhibition and Medicinal Chemistry,28(1),163-171;2013或WO2018089786等报道的方法制得;酰基化试剂、烷基化试剂及其它常规原料和试剂通常有市售,也可按照常规方法自制。The compound of general formula III-2 can be prepared by purchasing according to known methods, for example, refer to Organic Process Research & Development, 15(3), 556-564; 2011, Molecules, 17, 12187-12196; 2012, Chemical Communications (Cambridge, United Kingdom), 53(59), 8356-8359; 2017, Journal of Enzyme Inhibition and Medicinal Chemistry, 28(1), 163-171; Prepared by methods reported in 2013 or WO2018089786; acylation reagent, alkylation reagent and other conventional raw materials Reagents and reagents are usually commercially available, but can also be self-made according to conventional methods.
本发明通式I所示的化合物用于控制植物细菌性病害的用途,可用于防治多种植物细菌性病害,例如果斑病(如甜瓜果斑病等)、叶斑病(如番茄细菌性叶斑病等)、青枯病(如番茄青枯病、马铃薯青枯病等)、细菌性疫病、溃疡病(如柑橘溃疡病、猕猴桃溃疡病等)、软腐病(如大白菜软腐病等)、细菌性角斑病(如黄瓜细菌性角斑病等)、细菌性条斑病(如水稻细菌性条斑病等)、叶枯病、白叶枯病(如水稻白叶枯病等)、野火病和细菌性疮痂病等。The compound represented by the general formula I of the present invention is used to control plant bacterial diseases, and can be used to prevent and control a variety of plant bacterial diseases, such as fruit spot disease (such as melon fruit spot, etc.), leaf spot disease (such as tomato bacteria). Leaf spot disease, etc.), bacterial wilt (such as tomato bacterial wilt, potato bacterial wilt, etc.), bacterial blight, canker disease (such as citrus canker, kiwi fruit canker, etc.), soft rot (such as soft Chinese cabbage) Rot, etc.), bacterial angular leaf spot (e.g. cucumber bacterial angular leaf spot, etc.), bacterial leaf streak (e.g. rice bacterial leaf streak, etc.), leaf blight, bacterial leaf blight (e.g. rice white leaf Blight, etc.), wildfire and bacterial scab.
本发明的化合物也可用于防治在多种作物上由卵菌纲、担子菌纲、子囊菌和半知菌类等多种真菌引起的病害,例如在较低剂量下对黄瓜霜霉病、黄瓜灰霉病、黄瓜炭疽病、黄瓜白粉病、番茄早疫病、番茄晚疫病、辣椒疫病、葡萄霜霉病、葡萄白腐病、苹果轮纹病、苹果斑点落叶病、水稻纹枯病、水稻稻瘟病、小麦锈病、小麦叶斑病、小麦白粉病、油菜菌核病、玉米小斑病等病害都有着很好的防效。The compounds of the present invention can also be used to prevent and control diseases caused by various fungi such as Oomycetes, Basidiomycetes, Ascomycetes and Deuteromycetes on various crops. Gray mold, cucumber anthracnose, cucumber powdery mildew, tomato early blight, tomato late blight, pepper blight, grape downy mildew, grape white rot, apple ring leaf disease, apple spot leaf disease, rice sheath blight, rice paddy Diseases such as blast, wheat rust, wheat leaf spot, wheat powdery mildew, rape sclerotium, and corn spot disease have good control effects.
由于其积极的特性,上述化合物可有利地用于保护农业和园艺业重要的作物、家畜和种畜,以及人类常去的环境免于病菌的伤害。Due to its positive properties, the above-mentioned compounds can be advantageously used to protect important crops, livestock and breeding animals in agriculture and horticulture, and the environment frequently visited by humans from harmful bacteria.
为获得理想效果,化合物的用量因各种因素而改变,例如所用化合物、预保护的作物、有害生物的类型、感染程度、气候条件、施药方法、采用的剂型等。In order to obtain the desired effect, the dosage of the compound varies due to various factors, such as the compound used, the crop to be protected, the type of pest, the degree of infection, climatic conditions, the method of application, the dosage form used, and so on.
每公顷5克-5公斤的化合物剂量能提供充分的防治。A compound dose of 5 g-5 kg per hectare can provide adequate control.
本发明还包括以通式I化合物作为活性组分的杀菌剂。该杀菌剂中活性组分的重量百分含量在0.1-99%之间。该杀菌剂中还包括农业、林业、卫生上可接受的载体和助剂。The present invention also includes a bactericide with the compound of general formula I as the active ingredient. The weight percentage of the active components in the bactericide is between 0.1-99%. The fungicide also includes agricultural, forestry, and sanitary acceptable carriers and auxiliary agents.
本发明的杀菌剂可以制剂的形式施用。通式I化合物作为活性组分溶解或分散于载体和/或助剂中或配制成制剂以便作为杀菌使用时更易于分散。The bactericide of the present invention can be applied in the form of a formulation. The compound of general formula I is used as an active component to be dissolved or dispersed in a carrier and/or adjuvant or formulated into a preparation so as to be easier to disperse when used as a bactericidal agent.
本发明以通式I化合物为活性组分,可依照本领域所熟知的方式将通式I化合物制备成多种制剂类型,包括水剂、可溶性液剂、乳油、微乳剂、水乳剂、悬浮剂、悬浮种衣剂、可分散油悬浮剂、超低容量剂、粉剂、可湿性粉剂、可溶性粉剂、可乳化粉剂、颗粒剂、水分散粒剂、可溶性粒剂、可乳化粒剂、干悬浮剂、泡腾粒剂、漂浮粒剂、片剂、可溶性片剂、泡腾片剂、微胶囊粉剂、微胶囊悬浮剂,在任何情况下,制剂类型的选取取决于通式I化合 物的物理、化学和生物学特性。In the present invention, the compound of general formula I is used as the active component, and the compound of general formula I can be prepared into a variety of formulation types in a manner well known in the art, including water, soluble liquid, emulsifiable concentrate, microemulsion, water emulsion, and suspension. , Suspended seed coating agent, dispersible oil suspension agent, ultra-low volume agent, powder, wettable powder, soluble powder, emulsifiable powder, granule, water dispersible granule, soluble granule, emulsifiable granule, dry suspension agent , Effervescent granules, floating granules, tablets, soluble tablets, effervescent tablets, microcapsule powders, microcapsule suspensions, in any case, the choice of formulation type depends on the physics and chemistry of the compound of general formula I And biological characteristics.
本发明通式I化合物的杀菌制剂可由通常的加工方法制备,即将活性物质与液体载体或固体载体混合后,加入一种或几种表面活性剂如乳化剂、分散剂、润湿剂、增稠剂、稳定剂和消泡剂等。通常组合物中含有至少一种载体和至少一种表面活性剂。在各种情况下,应确保本发明组合物活性组分均匀分布。The bactericidal preparation of the compound of general formula I of the present invention can be prepared by the usual processing method, that is, after the active substance is mixed with a liquid carrier or a solid carrier, one or more surface active agents such as emulsifiers, dispersants, wetting agents, and thickening agents are added. Agents, stabilizers and defoamers, etc. Usually the composition contains at least one carrier and at least one surfactant. In all cases, it should be ensured that the active ingredient of the composition of the present invention is evenly distributed.
水剂是将通式I化合物、表面活性剂、水混合均匀,形成均一透明的液体。通常含有5~50%的活性成分,5~20%乳化剂,0~10%的其他添加剂如渗透剂,以及水余量。Aqueous agent is to mix the compound of general formula I, surfactant, and water uniformly to form a uniform and transparent liquid. It usually contains 5-50% of active ingredients, 5-20% of emulsifiers, 0-10% of other additives such as penetrants, and the balance of water.
可溶性液剂将通式I化合物、表面活性剂、非水极性溶剂混合均匀,形成均一透明液体。可溶性液剂中通常含有5~60%的活性成分,5~20%乳化剂,0~10%的其他添加剂如渗透剂,以及液体载体余量。The soluble liquid agent mixes the compound of general formula I, the surfactant, and the non-aqueous polar solvent uniformly to form a uniform transparent liquid. The soluble liquid usually contains 5-60% of active ingredients, 5-20% of emulsifiers, 0-10% of other additives such as penetrants, and the balance of the liquid carrier.
乳油将通式I化合物、表面活性剂、有机溶剂混合均匀,形成均相油状液体。乳油中通常含有1~70%的活性成分,5~20%乳化剂,0~10%的其他添加剂如渗透剂、稳定剂,以及液体载体余量。The emulsifiable concentrate mixes the compound of general formula I, the surfactant, and the organic solvent uniformly to form a homogeneous oily liquid. Emulsifiable concentrates usually contain 1 to 70% of active ingredients, 5 to 20% of emulsifiers, 0 to 10% of other additives such as penetrants, stabilizers, and the balance of the liquid carrier.
微乳剂将通式I化合物、表面活性剂、水、有机溶剂混合均匀,形成均一透明液体。微乳剂中通常含有1~50%的活性成分,5~30%乳化剂,2~10%防冻剂,0~10%的其他添加剂如渗透剂、稳定剂,以及液体载体余量。The microemulsion mixes the compound of general formula I, surfactant, water, and organic solvent uniformly to form a uniform transparent liquid. Microemulsions usually contain 1-50% of active ingredients, 5-30% of emulsifiers, 2-10% of antifreeze, 0-10% of other additives such as penetrants, stabilizers, and the balance of the liquid carrier.
水乳剂将通式I化合物、表面活性剂、有机溶剂混合均匀,制成油相;将水、防冻剂混合在一起,制成水相。用高剪切乳化机高速剪切油相,同时慢慢将水相加入油相,即可得到分散均匀的水乳剂。通常含有5~50%的活性成分,5~20%乳化剂,2~5%防冻剂,以及液体载体余量。In the water emulsion, the compound of general formula I, the surfactant, and the organic solvent are uniformly mixed to form the oil phase; the water and the antifreeze are mixed together to form the water phase. Use a high-shear emulsifier to shear the oil phase at high speed while slowly adding the water phase to the oil phase to obtain a uniformly dispersed water emulsion. It usually contains 5-50% active ingredient, 5-20% emulsifier, 2-5% antifreeze, and the balance of liquid carrier.
悬浮剂将通式I化合物、分散剂、润湿剂、防冻剂、水混合均匀后,经砂磨机砂磨,获得稳定的非沉积可流动的液体。悬浮剂中通常含有5~50%的活性成分,2~10%分散剂,2~5%润湿剂,2~5%防冻剂,0~10%其他添加剂如消泡剂、增稠剂、防腐剂,以及液体载体余量。The suspending agent mixes the compound of general formula I, dispersant, wetting agent, antifreeze, and water uniformly, and is sanded by a sand mill to obtain a stable, non-deposition, flowable liquid. Suspending agents usually contain 5-50% active ingredients, 2-10% dispersant, 2-5% wetting agent, 2-5% antifreeze, 0-10% other additives such as defoamers, thickeners, Preservative, and the balance of the liquid carrier.
悬浮种衣剂将通式I化合物、分散剂、润湿剂、成膜剂、水混合均匀后,经砂磨机砂磨,获得稳定的非沉积可流动的液体。悬浮种衣剂中通常含有1~50%的活性成分,2~10%分散剂,2~5%润湿剂,2~5%防冻剂,2~10%成膜剂,0~10%其他添加剂如消泡剂、增稠剂、防腐剂、警戒色,以及液体载体余量。The suspension seed coating agent is uniformly mixed with the compound of general formula I, dispersant, wetting agent, film-forming agent, and water, and then sanded by a sand mill to obtain a stable, non-deposition, flowable liquid. Suspended seed coatings usually contain 1-50% active ingredient, 2-10% dispersant, 2-5% wetting agent, 2-5% antifreeze, 2-10% film former, 0-10% others Additives such as defoamers, thickeners, preservatives, warning colors, and liquid carrier balance.
可分散油悬浮剂将通式I化合物、表面活性剂、油基载体混合均匀后,经砂磨机砂磨,获得稳定的非沉积可流动的液体。可分散油悬浮剂中通常含有5~50%的活性成分,5~30%表面活性剂,0~10%其他添加剂如增稠剂、稳定剂,以及液体载体余量。The dispersible oil suspension agent mixes the compound of general formula I, the surfactant, and the oil-based carrier uniformly, and is sanded by a sand mill to obtain a stable, non-deposition, flowable liquid. The dispersible oil suspension usually contains 5-50% of active ingredients, 5-30% of surfactants, 0-10% of other additives such as thickeners, stabilizers, and the balance of the liquid carrier.
超低容量剂将通式I化合物、表面活性剂、有机溶剂混合均匀,加工成均一透明油相。 通常含有1~30%的活性成分,5~30%乳化剂,0~10%的其他添加剂如稳定剂,以及液体载体余量。The ultra-low volume agent mixes the compound of general formula I, the surfactant, and the organic solvent uniformly, and processes it into a uniform transparent oil phase. It usually contains 1-30% of active ingredients, 5-30% of emulsifiers, 0-10% of other additives such as stabilizers, and the balance of the liquid carrier.
粉剂将通式I化合物、助剂、载体混合,经粉碎得到粉体物。粉剂通常含有5~85%的活性成分,5~10%分散剂,0~10%的其他添加剂如稳定剂,以及固体载体余量。The powder mixes the compound of general formula I, the auxiliary agent, and the carrier, and is pulverized to obtain a powder. The powder usually contains 5-85% of active ingredient, 5-10% of dispersant, 0-10% of other additives such as stabilizer, and the balance of solid carrier.
可湿性粉剂将通式I化合物、分散剂、润湿剂、载体混合,经粉碎得到粉体物。可湿性粉剂通常含有5~85%的活性成分,5~10%分散剂,1~10%润湿剂,0~10%的其他添加剂如稳定剂,以及固体载体余量。The wettable powder is mixed with a compound of general formula I, a dispersant, a wetting agent, and a carrier, and pulverized to obtain a powder. Wettable powders usually contain 5-85% of active ingredients, 5-10% of dispersants, 1-10% of wetting agents, 0-10% of other additives such as stabilizers, and the balance of solid carriers.
可溶性粉剂将通式I化合物、分散剂、润湿剂、载体混合,经粉碎得到粉体物。可溶性粉剂通常含有5~80%的活性成分,5~10%分散剂,1~10%润湿剂,0~10%的其他添加剂如稳定剂,以及固体载体余量。The soluble powder is mixed with a compound of general formula I, a dispersant, a wetting agent, and a carrier, and then pulverized to obtain a powder. The soluble powder usually contains 5 to 80% of active ingredients, 5 to 10% of dispersant, 1 to 10% of wetting agent, 0 to 10% of other additives such as stabilizers, and the balance of solid carrier.
可乳化粉剂将通式I化合物、表面活性剂、有机溶剂混合,制成均一透明油相,然后将上述油相均匀喷洒在预先粉碎好的载体上。可乳化粉剂通常含有5~50%的活性成分,5~30%乳化剂,5~10%润湿分散剂,0~15%的有机溶剂,以及固体载体余量。The emulsifiable powder is mixed with a compound of general formula I, a surfactant, and an organic solvent to prepare a uniform transparent oil phase, and then the above-mentioned oil phase is uniformly sprayed on the pre-pulverized carrier. The emulsifiable powder usually contains 5-50% active ingredient, 5-30% emulsifier, 5-10% wetting and dispersing agent, 0-15% organic solvent, and the balance of solid carrier.
颗粒剂将通式I化合物、助剂、载体混合,然后捏合、造粒、干燥、包衣。颗粒剂通常含有0.5~20%的活性成分,0.1~10%粘结剂,0~10%的其他添加剂如稳定剂,以及固体载体余量。The granule is mixed with the compound of general formula I, auxiliary agent and carrier, then kneaded, granulated, dried and coated. Granules usually contain 0.5-20% active ingredient, 0.1-10% binder, 0-10% other additives such as stabilizers, and the balance of solid carrier.
水分散粒剂将通式I化合物、分散剂、润湿剂、崩解剂、载体混合,然后捏合、造粒、干燥。水分散粒剂通常含有5~85%的活性成分,1~10%分散剂,1~10%润湿剂,0.1~10%粘结剂,0~10%的其他添加剂如崩解剂、稳定剂,以及固体载体余量。The water dispersible granules are mixed with the compound of general formula I, dispersant, wetting agent, disintegrant and carrier, then kneaded, granulated and dried. Water dispersible granules usually contain 5-85% active ingredient, 1-10% dispersant, 1-10% wetting agent, 0.1-10% binder, and 0-10% other additives such as disintegrant, stabilizer Agent, and the balance of the solid carrier.
可溶性粒剂将通式I化合物、分散剂、润湿剂、崩解剂、载体混合,然后捏合、造粒、干燥。可溶性粒剂通常含有5~85%的活性成分,1~10%分散剂,1~10%润湿剂,0.1~10%粘结剂,0~10%的其他添加剂如崩解剂、稳定剂,以及固体载体余量。The soluble granules are mixed with the compound of general formula I, dispersant, wetting agent, disintegrant and carrier, then kneaded, granulated and dried. Soluble granules usually contain 5-85% active ingredient, 1-10% dispersant, 1-10% wetting agent, 0.1-10% binder, and 0-10% other additives such as disintegrant and stabilizer , And the balance of the solid carrier.
可乳化粒剂将通式I化合物、表面活性剂、有机溶剂混合,制成均一透明油相,然后将上述油相均匀喷洒在预先粉碎好的载体上,捏合、造粒、干燥。可乳化粒剂通常含有5~50%的活性成分,5~30%乳化剂,5~10%润湿分散剂,0~15%的有机溶剂,0~10%的其他添加剂如崩解剂、稳定剂、粘结剂,以及固体载体余量。The emulsifiable granule mixes the compound of general formula I, the surfactant, and the organic solvent to form a uniform transparent oil phase, and then the oil phase is uniformly sprayed on the pre-pulverized carrier, kneaded, granulated, and dried. Emulsifiable granules usually contain 5-50% active ingredients, 5-30% emulsifiers, 5-10% wetting and dispersing agents, 0-15% organic solvents, and 0-10% other additives such as disintegrants, Stabilizer, binder, and the balance of solid carrier.
干悬浮剂将通式I化合物、分散剂、润湿剂、载体、水混合均匀后,经砂磨机砂磨,砂磨后进行喷雾干燥。干悬浮剂中通常含有5~80%的活性成分,2~20%分散剂,2~10%润湿剂,0~10%其他添加剂如消泡剂、增稠剂、以及固体载体余量。The dry suspending agent is uniformly mixed with the compound of general formula I, dispersant, wetting agent, carrier, and water, then sanded by a sand mill, and spray dried after sanding. Dry suspensions usually contain 5 to 80% of active ingredients, 2 to 20% of dispersing agents, 2 to 10% of wetting agents, and 0 to 10% of other additives such as defoamers, thickeners, and the balance of solid carriers.
泡腾粒剂将通式I化合物、润湿分散剂、泡腾崩解剂、载体混合,然后捏合、造粒。泡腾颗粒剂通常含有0.5~30%的活性成分,2~20%润湿分散剂,2~20%泡腾崩解剂,0~10%的 其他添加剂如稳定剂、粘结剂,以及固体载体余量。Effervescent granules: The compound of general formula I, wetting and dispersing agent, effervescent disintegrating agent, and carrier are mixed, then kneaded and granulated. Effervescent granules usually contain 0.5-30% active ingredient, 2-20% wetting and dispersing agent, 2-20% effervescent disintegrant, and 0-10% other additives such as stabilizers, binders, and solids. Carrier margin.
漂浮粒剂将通式I化合物、润湿分散剂、漂珠、载体混合,然后捏合、造粒。漂浮颗粒剂通常含有0.5~30%的活性成分,2~20%润湿分散剂,5~20%漂珠,0~10%的其他添加剂如稳定剂、粘结剂、崩解剂,以及固体载体余量。Floating granules are mixed with the compound of general formula I, wetting and dispersing agent, floating beads, and carrier, then kneaded and granulated. Floating granules usually contain 0.5-30% active ingredients, 2-20% wetting and dispersing agents, 5-20% floating beads, and 0-10% other additives such as stabilizers, binders, disintegrants, and solids. Carrier margin.
片剂将通式I化合物、分散剂、润湿剂、崩解剂、载体混合,然后捏合、压片、干燥。片剂通常含有5~50%的活性成分,1~10%分散剂,1~10%润湿剂,0.1~10%粘结剂,0~10%的其他添加剂如崩解剂、稳定剂,以及固体载体余量。The tablet is mixed with the compound of formula I, dispersant, wetting agent, disintegrant, and carrier, then kneaded, compressed, and dried. Tablets usually contain 5-50% active ingredient, 1-10% dispersant, 1-10% wetting agent, 0.1-10% binder, 0-10% other additives such as disintegrant, stabilizer, And the balance of the solid carrier.
可溶性片剂将通式I化合物、分散剂、润湿剂、崩解剂、载体混合,然后捏合、压片、干燥。可溶性片剂通常含有5~50%的活性成分,1~10%分散剂,1~10%润湿剂,0.1~10%粘结剂,0~10%的其他添加剂如崩解剂、稳定剂,以及固体载体余量。In the soluble tablet, the compound of general formula I, a dispersant, a wetting agent, a disintegrant, and a carrier are mixed, then kneaded, compressed, and dried. Soluble tablets usually contain 5-50% active ingredient, 1-10% dispersant, 1-10% wetting agent, 0.1-10% binder, and 0-10% other additives such as disintegrant and stabilizer , And the balance of the solid carrier.
泡腾片剂将通式I化合物、润湿分散剂、泡腾崩解剂、载体混合,然后捏合、压片。泡腾片剂通常含有0.5~30%的活性成分,2~20%润湿分散剂,2~20%泡腾崩解剂,0~10%的其他添加剂如稳定剂、粘结剂,以及固体载体余量。An effervescent tablet is mixed with the compound of general formula I, a wetting and dispersing agent, an effervescent disintegrant, and a carrier, then kneaded and compressed. Effervescent tablets usually contain 0.5-30% active ingredients, 2-20% wetting and dispersing agents, 2-20% effervescent disintegrants, and 0-10% other additives such as stabilizers, binders, and solids. Carrier margin.
微胶囊粉剂将通式I化合物溶于溶剂中,向其中加入乳化剂和壁材,搅拌均匀,得到油相;水中加入分散剂得到水相;在高速搅拌下,将油相加入水相中,形成水包油型乳状液;在搅拌条件下,向乳状液中加入固化剂,加热保温成囊,然后过滤、干燥。微胶囊粉剂通常含有0.5~30%的活性成分,2~10%乳化剂,2~10%润湿分散剂,5~30%的其他添加剂如壁材、消泡剂、固化剂、稳定剂,以及固体载体余量。Microcapsule powder dissolve the compound of general formula I in a solvent, add emulsifier and wall materials to it, stir evenly to obtain an oil phase; add a dispersant to the water to obtain an aqueous phase; under high-speed stirring, add the oil phase to the water phase, An oil-in-water emulsion is formed; under agitation, a curing agent is added to the emulsion, heated and kept to form a capsule, and then filtered and dried. Microcapsule powders usually contain 0.5-30% active ingredients, 2-10% emulsifiers, 2-10% wetting and dispersing agents, and 5-30% other additives such as wall materials, defoamers, curing agents, stabilizers, And the balance of the solid carrier.
微胶囊悬浮剂将通式I化合物溶于溶剂中,向其中加入乳化剂和壁材,搅拌均匀,得到油相;水中加入分散剂得到水相;在高速搅拌下,将油相加入水相中,形成水包油型乳状液;在搅拌条件下,向乳状液中加入固化剂,加热保温成囊,形成微囊悬浮剂。微胶囊悬浮剂通常含有0.5~30%的活性成分,2~10%乳化剂,2~10%润湿分散剂,5~30%的其他添加剂如壁材、消泡剂、防腐剂、增稠剂、固化剂、稳定剂,以及液体载体余量。Microcapsule suspending agent dissolve the compound of general formula I in a solvent, add emulsifier and wall materials to it, stir evenly to obtain an oil phase; add a dispersant to the water to obtain an aqueous phase; under high-speed stirring, add the oil phase to the water phase , To form an oil-in-water emulsion; under agitation, add a curing agent to the emulsion, heat and keep it to form a capsule to form a microcapsule suspension. Microcapsule suspensions usually contain 0.5-30% active ingredients, 2-10% emulsifiers, 2-10% wetting and dispersing agents, and 5-30% other additives such as wall materials, defoamers, preservatives, thickening Agent, curing agent, stabilizer, and the balance of the liquid carrier.
本发明通式I化合物的杀菌制剂的配制可以采用本领域的技术人员公知的(液体或固体)载体和各种助剂。例如包括但不限于下述各类物质。The preparation of the bactericidal preparation of the compound of the general formula I of the present invention can adopt the well-known (liquid or solid) carriers and various auxiliary agents by those skilled in the art. Examples include but are not limited to the following types of substances.
本发明通式I化合物的杀菌制剂中适宜的表面活性剂,可以是乳化剂、分散剂或湿润剂;可以是非离子型或离子型中的一种或几种。离子型表面活性剂选自磺酸盐类、硫酸盐类、羧酸盐类、磷酸酯盐类、琥珀酸酯盐类、木质素磺酸盐类、丙烯酰胺丙烯酸共聚物类等。非离子表面活性剂选自脂肪醇聚氧乙烯醚、烷基酚聚氧乙烯醚、脂肪胺聚氧乙烯醚、脂肪酸聚氧乙烯醚、酸醇酯及其聚氧乙烯醚、烷基聚乙二醇醚、烷基苯基聚乙二醇醚、脂肪酰胺及其聚氧乙烯醚、烷醇酰胺及其聚氧乙烯醚、聚氧乙烯聚氧丙烯醚嵌段共聚物、烷基萘磺酸钠脂 肪醇聚氧乙烯基醚、失水山梨醇脂肪酸酯聚氧乙烯基醚等。The suitable surfactant in the bactericidal preparation of the compound of general formula I of the present invention can be an emulsifier, a dispersant or a wetting agent; it can be one or more of non-ionic or ionic. The ionic surfactant is selected from sulfonates, sulfates, carboxylates, phosphate salts, succinate salts, lignosulfonates, acrylamide acrylic copolymers and the like. Nonionic surfactants are selected from fatty alcohol polyoxyethylene ethers, alkylphenol polyoxyethylene ethers, fatty amine polyoxyethylene ethers, fatty acid polyoxyethylene ethers, acid alcohol esters and their polyoxyethylene ethers, alkyl polyethylene glycols Alcohol ether, alkyl phenyl polyglycol ether, fatty amide and its polyoxyethylene ether, alkanolamide and its polyoxyethylene ether, polyoxyethylene polyoxypropylene ether block copolymer, sodium alkyl naphthalene sulfonate Fatty alcohol polyoxyethylene ether, sorbitan fatty acid ester polyoxyethylene ether, etc.
上述表面活性剂可选自所示表面活性剂中的一种或几种,如:木质素磺酸钠盐或钙盐、聚氧乙烯(n20)苯乙基酚基醚油酸酯、烷基芳基聚氧乙烯聚氧丙烯醚、三苯乙烯基酚聚氧乙烯(n20)醚磷酸化三乙醇胺盐、农乳0201B、农乳0203B、农乳100#、农乳600#、农乳700#、农乳1601#、农乳AEO-3、农乳AEO-5、农乳AEO-7、农乳T-20、农乳T-80、农乳T-85、农乳S-80、农乳S-85、农乳NP-7、农乳NP-10、农乳NP-15、农乳OX-2681、农乳OX-8686、农乳OX-690、农乳2201#、聚羧酸盐分散剂GY-D800、聚羧酸盐分散剂GY-D04、聚羧酸盐分散剂GY-D02、烷基萘磺酸盐甲醛缩合物(NNO)、萘酚磺酸甲醛缩合物钠盐、烷基酚聚氧乙烯聚氧丙烯醚、苯乙烯马来酸酐、甲基萘磺酸甲醛缩合物、蓖麻油环氧乙烷加成物、烷基酚聚氧乙烯聚氧丙烯醚、烷基-二乙二醇醚-磺酸钠、N-甲基-油酰基-牛磺酸钠、净洗剂LS、亚甲基萘磺酸钠、油酸甲基氨基乙基磺酸钠、分散剂SP-28F、分散剂SP-SC3、达润分散剂D909S、烷基芳基聚氧乙烯醚、十二烷基聚氧乙烯醚磷酸酯、烷基酚聚氧乙烯醚甲醛缩合物、二丁基萘磺酸钠(拉开粉BX)、二丁基萘磺酸甲醛缩合物、分散剂SD-811、分散剂SD815、分散剂SK-24、分散剂SK-20TX、分散剂SK-5218、分散剂SK-33H、分散剂SK-10LX、分散剂SK-551、分散剂Atlox 4913、分散剂EL-20、分散剂EL-40、分散剂EL-90、分散剂YUS-NV1203、分散剂YUS-NV1420、分散剂YUS-WG4、分散剂YUS-TG285、分散剂YUS-WP1、分散剂YUS-110、分散剂YUS-EP60P、分散剂YUS-CH1100、分散剂SP-OF3468、分散剂SP-OF3472、分散剂SP-2728、分散剂SP-SC29、分散剂Supragil MNS/90、分散剂Soprophor FD、分散剂YUS-FS1、分散剂YUS-PQ100、分散剂YUS-WG5、YUS-D935、辛基酚聚氧乙烯基醚硫酸盐、Morwet EFW、润湿剂Igepal BC/10、润湿剂GEROPONL-WET/P、润湿剂Rhodasurf 860/p、润湿剂SP-SC3266、润湿剂PICO-SW2、润湿剂PICO-SW3、润湿剂YUS-LXC、润湿剂YUS-204、烷基醇聚氧乙烯基醚硫酸钠、烷基酚聚氧乙烯基醚甲醛缩合物硫酸盐、烷基丁二酸磺酸盐、十二烷基苯磺酸钠、十二烷基硫酸钠、十二烷基苯磺酸钙等。The above-mentioned surfactants can be selected from one or more of the surfactants shown, such as: sodium or calcium lignosulfonate, polyoxyethylene (n20) phenethyl phenol ether oleate, alkyl Aryl polyoxyethylene polyoxypropylene ether, tristyryl phenol polyoxyethylene (n20) ether phosphorylated triethanolamine salt, agricultural milk 0201B, agricultural milk 0203B, agricultural milk 100#, agricultural milk 600#, agricultural milk 700# , Nong Milk 1601#, Nong Milk AEO-3, Nong Milk AEO-5, Nong Milk AEO-7, Nong Milk T-20, Nong Milk T-80, Nong Milk T-85, Nong Milk S-80, Nong Milk S-85, agricultural milk NP-7, agricultural milk NP-10, agricultural milk NP-15, agricultural milk OX-2681, agricultural milk OX-8686, agricultural milk OX-690, agricultural milk 2201#, polycarboxylate dispersion GY-D800, polycarboxylate dispersant GY-D04, polycarboxylate dispersant GY-D02, alkyl naphthalene sulfonate formaldehyde condensate (NNO), naphthol sulfonate formaldehyde condensate sodium salt, alkyl Phenol polyoxyethylene polyoxypropylene ether, styrene maleic anhydride, methyl naphthalenesulfonic acid formaldehyde condensate, castor oil ethylene oxide adduct, alkylphenol polyoxyethylene polyoxypropylene ether, alkyl-diethyl Glycol ether-sodium sulfonate, N-methyl-oleoyl-sodium taurate, detergent LS, sodium methylene naphthalene sulfonate, sodium oleic acid methyl amino ethyl sulfonate, dispersant SP-28F , Dispersant SP-SC3, Darun dispersant D909S, alkyl aryl polyoxyethylene ether, dodecyl polyoxyethylene ether phosphate, alkylphenol polyoxyethylene ether formaldehyde condensate, dibutyl naphthalene sulfonic acid Sodium (pulverized powder BX), dibutyl naphthalenesulfonic acid formaldehyde condensate, dispersant SD-811, dispersant SD815, dispersant SK-24, dispersant SK-20TX, dispersant SK-5218, dispersant SK- 33H, dispersant SK-10LX, dispersant SK-551, dispersant Atlox 4913, dispersant EL-20, dispersant EL-40, dispersant EL-90, dispersant YUS-NV1203, dispersant YUS-NV1420, dispersant Dispersant YUS-WG4, dispersant YUS-TG285, dispersant YUS-WP1, dispersant YUS-110, dispersant YUS-EP60P, dispersant YUS-CH1100, dispersant SP-OF3468, dispersant SP-OF3472, dispersant SP -2728, dispersant SP-SC29, dispersant Supragil MNS/90, dispersant Soprophor FD, dispersant YUS-FS1, dispersant YUS-PQ100, dispersant YUS-WG5, YUS-D935, octylphenol polyoxyethylene Ether sulfate, Morwet EFW, wetting agent Igepal BC/10, wetting agent GEROPONL-WET/P, wetting agent Rhodasurf 860/p, wetting agent SP-SC3266, wetting agent PICO-SW2, wetting agent PICO -SW3, Wetting agent YUS-LXC, wetting agent YUS-204, sodium alkyl alcohol polyoxyethylene ether sulfate, alkylphenol polyoxyethylene ether formaldehyde condensate sulfate, alkyl succinic acid sulfonate, twelve Sodium alkyl benzene sulfonate, sodium dodecyl sulfate, calcium dodecyl benzene sulfonate, etc.
本发明通式I化合物的杀菌制剂中适宜的液体载体可以是水、有机溶剂、油性介质中的一种或几种。适宜的有机溶剂选自芳烃、氯代芳烃、脂族烃、氯代脂族烃、醇类以及它们的醚和酯、酮类等,例如苯、二甲苯、甲苯、烷基苯、烷基萘、氯代苯、氯乙烯、三氯乙烷、二氯甲烷、氯仿、四氯化碳、多氯乙烷、石油馏分、环己烷、甲醇、乙醇、异丙醇、丁醇、乙二醇、丙二醇、丙三醇、山梨醇、苯甲醇、糠醇、环己醇、丙酮、甲乙酮、甲基异丁基酮、环己酮、N-甲基-吡咯烷酮、磷酸三丁酯、二甲基甲酰胺和二甲基亚砜等。适宜的油性介质选自大豆油、油酸甲酯、轻质矿物油、液体石蜡、煤油、松节油等。The suitable liquid carrier in the bactericidal preparation of the compound of general formula I of the present invention can be one or more of water, organic solvent, and oily medium. Suitable organic solvents are selected from aromatic hydrocarbons, chlorinated aromatic hydrocarbons, aliphatic hydrocarbons, chlorinated aliphatic hydrocarbons, alcohols and their ethers and esters, ketones, etc., such as benzene, xylene, toluene, alkylbenzene, alkylnaphthalene , Chlorobenzene, vinyl chloride, trichloroethane, dichloromethane, chloroform, carbon tetrachloride, polychloroethane, petroleum fractions, cyclohexane, methanol, ethanol, isopropanol, butanol, ethylene glycol , Propylene glycol, glycerol, sorbitol, benzyl alcohol, furfuryl alcohol, cyclohexanol, acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone, N-methyl-pyrrolidone, tributyl phosphate, dimethyl methyl Amide and dimethyl sulfoxide, etc. Suitable oily medium is selected from soybean oil, methyl oleate, light mineral oil, liquid paraffin, kerosene, turpentine and the like.
本发明通式I化合物的杀菌制剂中适宜的固体载体包括天然的或合成的。可选自但不 限于粘土、岩石粉末、白垩、石英、粘土、蒙脱土、硫酸钠、二氧化硅、硅藻土、浮石、石膏、滑石、膨润土、高岭土、凹凸棒土、轻质碳酸钙、陶土、蒙脱土、硅酸铝镁、活性白土、白碳黑、硫酸铵、苯并呋喃树脂、过磷酸盐、氧化铝、方解石、大理石、浮石等,合适的颗粒载体包括破碎的和分级的天然岩石例如海泡石和白云石和由有机和无机的粉末制成的合成颗粒。Suitable solid carriers in the bactericidal preparation of the compound of general formula I of the present invention include natural or synthetic ones. Can be selected from but not limited to clay, rock powder, chalk, quartz, clay, montmorillonite, sodium sulfate, silica, diatomaceous earth, pumice, gypsum, talc, bentonite, kaolin, attapulgite, light calcium carbonate , Clay, montmorillonite, magnesium aluminum silicate, activated clay, white carbon black, ammonium sulfate, benzofuran resin, superphosphate, alumina, calcite, marble, pumice, etc. Suitable particle carriers include crushed and classified Natural rocks such as sepiolite and dolomite and synthetic particles made of organic and inorganic powders.
适宜的粘合剂、增稠剂包括合成的或天然的水溶性聚合物。可选自但不限于羰甲基醇、聚乙烯醇、聚乙酸乙烯酯、黄原胶、明胶、阿拉伯树胶、聚乙烯吡咯烷酮、硅酸镁铝、聚乙烯醇、聚乙二醇、酚醛树脂、虫胶、甲基纤维素、可溶性淀粉、羧甲基纤维素和海藻酸钠等,以粉末、颗粒或胶乳形式加入制剂中。Suitable binders and thickeners include synthetic or natural water-soluble polymers. Can be selected from but not limited to carbonyl methyl alcohol, polyvinyl alcohol, polyvinyl acetate, xanthan gum, gelatin, gum arabic, polyvinylpyrrolidone, magnesium aluminum silicate, polyvinyl alcohol, polyethylene glycol, phenolic resin, Shellac, methyl cellulose, soluble starch, carboxymethyl cellulose and sodium alginate, etc., are added to the preparation in the form of powder, granules or latex.
适宜的消泡剂可选自但不限于消泡剂SAG1522、硅酮类、C8~10脂肪醇、磷酸酯类、C10~20饱和脂肪酸类(如癸酸)及酰胺等。Suitable defoamers can be selected from, but not limited to, defoamers SAG1522, silicones, C8-10 fatty alcohols, phosphate esters, C10-20 saturated fatty acids (such as capric acid), amides, and the like.
适宜的防冻剂可选自但不限于乙醇、异丙醇、乙二醇、丙二醇、丙三醇、二甘醇、乙二醇丁醚、丙二醇丁醚、乙二醇丁醚乙酸酯、尿素等。Suitable antifreeze can be selected from but not limited to ethanol, isopropanol, ethylene glycol, propylene glycol, glycerol, diethylene glycol, ethylene glycol butyl ether, propylene glycol butyl ether, ethylene glycol butyl ether acetate, urea Wait.
适宜的渗透剂可选自但不限于有机硅、渗透剂T、渗透剂JFC等。Suitable penetrants can be selected from, but not limited to, silicone, penetrant T, penetrant JFC, and the like.
适宜的成膜剂包括天然产物及其改性物和人工合成高分子。可选自但不限于羧甲基淀粉钠、可溶性淀粉、磷酸化淀粉、氧化淀粉、壳聚糖及其衍生物、聚丙烯接枝共聚物、黄原胶、海藻酸钠、琼脂、明胶、阿拉伯胶、聚乙二醇、聚乙烯醇、聚醋酸乙烯酯、聚丙烯酰胺、聚乙烯吡咯烷酮、聚丙烯酸等。Suitable film-forming agents include natural products and their modifications and synthetic polymers. Can be selected from but not limited to sodium carboxymethyl starch, soluble starch, phosphorylated starch, oxidized starch, chitosan and its derivatives, polypropylene graft copolymer, xanthan gum, sodium alginate, agar, gelatin, arabic Glue, polyethylene glycol, polyvinyl alcohol, polyvinyl acetate, polyacrylamide, polyvinylpyrrolidone, polyacrylic acid, etc.
适宜的防腐剂可选自但不限于苯甲酸钠、卡松、山梨酸钾等。Suitable preservatives can be selected from, but not limited to, sodium benzoate, cassone, potassium sorbate and the like.
适宜的崩解剂可选自但不限于羧甲基淀粉钠、交联羧甲基淀粉钠、交联羧甲基纤维素钠、改性淀粉、交联聚乙烯吡咯烷酮、硫酸铵、硫酸钠、氯化钠、氯化铵等。Suitable disintegrants can be selected from but not limited to sodium carboxymethyl starch, croscarmellose sodium, croscarmellose sodium, modified starch, cross-linked polyvinylpyrrolidone, ammonium sulfate, sodium sulfate, Sodium chloride, ammonium chloride, etc.
泡腾崩解剂可为酸性组分和/或碱性组分,其中酸性组分可选自有机酸、无机酸,例如:酒石酸、柠檬酸、水杨酸、磷酸等;碱性组分可选自碱式碳酸盐、碳酸盐,例如:碳酸氢钠、碳酸钠、碳酸氢钾、碳酸钾、碳酸氢铵等。The effervescent disintegrant can be an acidic component and/or an alkaline component, wherein the acidic component can be selected from organic acids and inorganic acids, such as tartaric acid, citric acid, salicylic acid, phosphoric acid, etc.; the alkaline component can be It is selected from basic carbonates and carbonates, for example: sodium bicarbonate, sodium carbonate, potassium bicarbonate, potassium carbonate, ammonium bicarbonate and the like.
适宜的警戒色可选自但不限于无机颜料,如氧化铁、氧化钛或普鲁士兰;有机染料,如阿利札林、酸性大红G、碱性玫瑰精、偶氮染料、金属酞菁等。Suitable warning colors can be selected from, but not limited to, inorganic pigments, such as iron oxide, titanium oxide or Prussian blue; organic dyes, such as alizarine, acid scarlet G, basic rose spirit, azo dyes, metal phthalocyanines, and the like.
适宜的壁材包括天然高分子材料、半合成高分子材料和全合成高分子材料中的一种或几种。天然高分子材料可选自但不限于明胶、阿拉伯胶、琼脂、海藻酸盐、壳聚糖、纤维蛋白、玉米蛋白等;半合成高分子材料可选自但不限于甲(乙)基纤维素、羧甲基纤维素(钠)、醋酸纤维素及其酯类和部分甘油酯等;全合成高分子材料可选自但不限于聚丙烯酸树酯、脲醛树脂、聚酰胺、聚酯、聚甲基丙烯酸甲酯、聚脲、聚氨酯等。Suitable wall materials include one or more of natural polymer materials, semi-synthetic polymer materials and fully synthetic polymer materials. The natural polymer material can be selected from but not limited to gelatin, acacia, agar, alginate, chitosan, fibrin, zein, etc.; the semi-synthetic polymer material can be selected from but not limited to methyl (ethyl) cellulose , Carboxymethyl cellulose (sodium), cellulose acetate and its esters and partial glycerides, etc.; fully synthetic polymer materials can be selected from but not limited to polyacrylic resin, urea resin, polyamide, polyester, polymethyl Methyl acrylate, polyurea, polyurethane, etc.
适宜的固化剂包括多元醇、多元胺中的一种或几种。多元醇可选自但不限于乙二醇、丙三醇、1,2-丙二醇、1,4-丁二醇、二乙二醇、聚乙二醇200、聚乙二醇400、聚乙二醇600等;多元胺可选自但不限于乙二胺、丙二胺、己二胺、二乙烯三胺、三乙烯四胺、乙醇胺、二乙醇胺、三乙醇胺、六亚甲基四胺、异佛尔酮二胺等。Suitable curing agents include one or more of polyols and polyamines. The polyol can be selected from but not limited to ethylene glycol, glycerol, 1,2-propylene glycol, 1,4-butanediol, diethylene glycol, polyethylene glycol 200, polyethylene glycol 400, polyethylene glycol Alcohol 600, etc.; polyamines can be selected from but not limited to ethylene diamine, propylene diamine, hexamethylene diamine, diethylene triamine, triethylene tetramine, ethanolamine, diethanolamine, triethanolamine, hexamethylenetetramine, iso Folone diamine and so on.
本发明通式I化合物的杀菌制剂在使用前可以由使用者经稀释或直接兑水喷雾,也可以直接使用。The bactericidal preparation of the compound of general formula I of the present invention can be diluted or sprayed directly with water by the user before use, or it can be used directly.
本发明的技术方案还包括防治病菌的方法:将本发明的杀菌剂施于所述的病菌或其生长介质上。通常选择的较为适宜有效量为每公顷10克到1000克,优选有效量为每公顷10克到500克。The technical scheme of the present invention also includes a method for preventing and curing pathogens: applying the fungicidal agent of the present invention to the pathogens or their growth medium. Generally, the more suitable effective amount is selected to be 10 g to 1000 g per hectare, and the effective amount is preferably 10 to 500 g per hectare.
应明确的是,在本发明的权利要求所限定的范围内,可进行各种变换和改动。It should be clear that various changes and modifications can be made within the scope defined by the claims of the present invention.
具体实施方式detailed description
以下具体实施例用来进一步说明本发明,但本发明绝非限于这些例子。(除另有注明外,所用原料均有市售)The following specific examples are used to further illustrate the present invention, but the present invention is by no means limited to these examples. (Unless otherwise noted, all raw materials used are commercially available)
合成实施例Synthesis Example
按照上述记载的合成路线,采用不同的原料化合物,即可分别制备获得本发明通式I所示化合物,进一步具体描述如下:According to the synthetic route described above, using different raw material compounds, the compounds represented by the general formula I of the present invention can be prepared separately, which are further described in detail as follows:
实施例1:化合物1的制备Example 1: Preparation of Compound 1
Figure PCTCN2021093237-appb-000030
Figure PCTCN2021093237-appb-000030
将1.00g(3.58mmol)(4-(5-(三氟甲基)-1,2,4-噁二唑-3-基)苯基)甲胺盐酸盐(参照WO2018184984报道的方法制得)放入50ml单口瓶中,加入20ml乙醇并摇匀至充分混合,加入0.37g(3.66mmol)三乙胺、0.44g(3.61mmol)乙氧基亚甲基丙二腈,室温下搅拌反应。TLC监测反应完毕后,减压脱溶,残余物柱层析后得目标产物白色固体0.93g。化合物1的 1H NMR及液质数据如下: 1.00g (3.58mmol) (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)methanamine hydrochloride (referring to the method reported in WO2018184984) ) Put it into a 50ml single-necked flask, add 20ml ethanol and shake it until fully mixed, add 0.37g (3.66mmol) triethylamine, 0.44g (3.61mmol) ethoxymethylenemalononitrile, and stir to react at room temperature. After the reaction was monitored by TLC, the solvent was removed under reduced pressure, and the residue was column chromatographed to obtain 0.93 g of the target product as a white solid. The 1 H NMR and liquid quality data of compound 1 are as follows:
1H NMR(600MHz,Chloroform-d)δ8.19(d,2H),7.48–7.37(m,3H),6.87(br s,1H),4.58(d,2H).LC-MS(m/z,ESI):320.1(M+H). 1 H NMR(600MHz, Chloroform-d)δ8.19(d,2H), 7.48--7.37(m,3H), 6.87(br s,1H), 4.58(d,2H).LC-MS(m/z ,ESI): 320.1(M+H).
实施例2:化合物12的制备Example 2: Preparation of compound 12
Figure PCTCN2021093237-appb-000031
Figure PCTCN2021093237-appb-000031
25ml单口瓶中加入0.25g(0.78mmol)N-(4-(5-(三氟甲基)-1,2,4-噁二唑-3-基)苯基)羰酰基二氰胺、15ml甲苯、0.08g(0.87mmol)丙酰氯,升温回流反应。TLC监测反应完毕后,减压脱溶,残余物柱层析后得目标产物棕色固体0.24g。化合物12的 1H NMR数据如下: Add 0.25g (0.78mmol) N-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)carbonyl dicyandiamide, 15ml to a 25ml single-mouth bottle Toluene, 0.08g (0.87mmol) propionyl chloride, heated and refluxed for reaction. After the reaction was monitored by TLC, the solvent was removed under reduced pressure, and the residue was column chromatographed to obtain 0.24 g of the target product as a brown solid. The 1 H NMR data of compound 12 are as follows:
1H NMR(600MHz,Chloroform-d)δ8.28(s,1H),8.17(d,2H),7.30(d,2H),5.40(s,2H),2.67(q,2H),1.27(d,3H). 1 H NMR (600MHz, Chloroform-d) δ 8.28 (s, 1H), 8.17 (d, 2H), 7.30 (d, 2H), 5.40 (s, 2H), 2.67 (q, 2H), 1.27 (d ,3H).
实施例3:化合物13的制备Example 3: Preparation of Compound 13
Figure PCTCN2021093237-appb-000032
Figure PCTCN2021093237-appb-000032
参照实施例2的合成方法制得化合物13(黄色固体)。化合物13的 1H NMR数据如下: According to the synthesis method of Example 2, compound 13 (yellow solid) was prepared. The 1 H NMR data of compound 13 are as follows:
1H NMR(600MHz,Chloroform-d)δ8.27(s,1H),8.17(d,2H),7.30(d,2H),5.40(s,2H),2.61(t,2H),1.82–1.72(m,2H),0.99(t,3H). 1 H NMR (600MHz, Chloroform-d) δ 8.27 (s, 1H), 8.17 (d, 2H), 7.30 (d, 2H), 5.40 (s, 2H), 2.61 (t, 2H), 1.82-1.72 (m,2H),0.99(t,3H).
实施例4:化合物14的制备Example 4: Preparation of compound 14
Figure PCTCN2021093237-appb-000033
Figure PCTCN2021093237-appb-000033
参照实施例2的合成方法制得化合物14(棕色固体)。化合物14的 1H NMR及液质数据如下: 1H NMR(600MHz,Chloroform-d)δ8.22(s,1H),8.17(d,2H),7.29(d,2H),5.41(s,2H),3.07–2.98(m,1H),1.55(s,6H).LC-MS(m/z,ESI):388.4(M-H). According to the synthesis method of Example 2, compound 14 (brown solid) was prepared. The 1 H NMR and liquid quality data of compound 14 are as follows: 1 H NMR (600MHz, Chloroform-d) δ 8.22(s, 1H), 8.17(d, 2H), 7.29(d, 2H), 5.41(s, 2H) ),3.07--2.98(m,1H),1.55(s,6H).LC-MS(m/z,ESI): 388.4(MH).
实施例5:化合物15的制备Example 5: Preparation of Compound 15
Figure PCTCN2021093237-appb-000034
Figure PCTCN2021093237-appb-000034
参照实施例2的合成方法制得化合物15(棕色油状物)。化合物15的 1H NMR数据如下: Referring to the synthesis method of Example 2, compound 15 (brown oil) was prepared. The 1 H NMR data of compound 15 are as follows:
1H NMR(600MHz,Chloroform-d)δ8.26(s,1H),8.17(d,2H),7.30(d,2H),5.40(s,2H),2.63(t,2H),1.77–1.67(m,2H),1.42–1.32(m,2H),0.93(t,3H). 1 H NMR (600MHz, Chloroform-d) δ 8.26 (s, 1H), 8.17 (d, 2H), 7.30 (d, 2H), 5.40 (s, 2H), 2.63 (t, 2H), 1.77-1.67 (m,2H),1.42-1.32(m,2H),0.93(t,3H).
实施例6:化合物16的制备Example 6: Preparation of compound 16
Figure PCTCN2021093237-appb-000035
Figure PCTCN2021093237-appb-000035
参照实施例2的合成方法制得化合物16(黄色油状物)。化合物16的 1H NMR数据如下: According to the synthesis method of Example 2, compound 16 (yellow oil) was prepared. The 1 H NMR data of compound 16 are as follows:
1H NMR(600MHz,Chloroform-d)δ8.46(s,1H),8.17(d,2H),7.35(d,2H),5.49(s,2H),1.90–1.83(m,1H),1.31–1.26(m,2H),1.16–1.10(m,2H). 1 H NMR(600MHz, Chloroform-d) δ8.46(s,1H), 8.17(d,2H), 7.35(d,2H), 5.49(s,2H), 1.90-1.83(m,1H), 1.31 –1.26(m,2H),1.16–1.10(m,2H).
实施例7:化合物19的制备Example 7: Preparation of Compound 19
(1)中间体2-环丙基乙酰氯的合成(1) Synthesis of intermediate 2-cyclopropyl acetyl chloride
Figure PCTCN2021093237-appb-000036
Figure PCTCN2021093237-appb-000036
将0.11g(1.1mmol)环丙基乙酸放入25ml单口瓶中,加入15ml氯化亚砜,升温回流反应3小时。冷却至室温,减压脱溶后直接用于下步反应。0.11 g (1.1 mmol) of cyclopropyl acetic acid was put into a 25 ml single-necked flask, 15 ml of thionyl chloride was added, and the reaction was heated and refluxed for 3 hours. After cooling to room temperature, it was directly used in the next reaction after desolving under reduced pressure.
(2)化合物19的合成(2) Synthesis of compound 19
Figure PCTCN2021093237-appb-000037
Figure PCTCN2021093237-appb-000037
25ml反应瓶中,依次加入上步制备的2-环丙基乙酰氯、15ml二氯甲烷、0.30g(0.94mmol)N-(4-(5-(三氟甲基)-1,2,4-噁二唑-3-基)苯基)羰酰基二氰胺、0.19g(1.88mmol)三乙胺,室温搅拌反应。TLC监测反应完毕后,减压脱溶,残余物柱层析后得目标产物黄色油状物0.31g。化合物19的 1H NMR数据如下: In a 25ml reaction flask, add 2-cyclopropylacetyl chloride prepared in the previous step, 15ml dichloromethane, 0.30g (0.94mmol) N-(4-(5-(trifluoromethyl)-1,2,4 -Oxadiazol-3-yl)phenyl)carbonyldicyanamide, 0.19g (1.88mmol) of triethylamine, stirred and reacted at room temperature. After the reaction was monitored by TLC, the solvent was removed under reduced pressure, and the residue was column chromatographed to obtain 0.31 g of the target product as a yellow oil. The 1 H NMR data of compound 19 are as follows:
1H NMR(600MHz,DMSO-d 6)δ9.31(s,1H),8.00(d,2H),7.44(d,2H),4.86(s,2H),2.81(d,2H),1.07–0.97(m,1H),0.52–0.46(m,2H),0.17–0.11(m,2H). 1 H NMR(600MHz,DMSO-d 6 )δ9.31(s,1H),8.00(d,2H),7.44(d,2H),4.86(s,2H),2.81(d,2H),1.07-- 0.97 (m, 1H), 0.52-0.46 (m, 2H), 0.17-0.11 (m, 2H).
实施例8:化合物22的制备Example 8: Preparation of Compound 22
Figure PCTCN2021093237-appb-000038
Figure PCTCN2021093237-appb-000038
参照实施例2的合成方法制得化合物22(黄色固体)。化合物22的 1H NMR及液质数据如下: 1H NMR(600MHz,DMSO-d 6)δ8.39(s,1H),8.06(d,2H),7.46(d,2H),5.31(s,2H),4.74(s,2H),3.34(s,3H).LC-MS(m/z,ESI):390.4(M-H). According to the synthesis method of Example 2, compound 22 (yellow solid) was prepared. The 1 H NMR and liquid quality data of compound 22 are as follows: 1 H NMR (600MHz, DMSO-d 6 )δ8.39(s,1H), 8.06(d,2H),7.46(d,2H),5.31(s, 2H), 4.74(s, 2H), 3.34(s, 3H). LC-MS(m/z, ESI): 390.4(MH).
实施例9:化合物34的制备Example 9: Preparation of Compound 34
Figure PCTCN2021093237-appb-000039
Figure PCTCN2021093237-appb-000039
参照实施例2的合成方法制得化合物34(白色固体)。化合物34的 1H NMR及液质数据如下: 1H NMR(600MHz,DMSO-d 6)δ8.20(s,1H),8.09(d,2H),7.63(d,2H),4.95(s,2H),2.81(s, 6H).LC-MS(m/z,ESI):389.2(M-H). Refer to the synthesis method of Example 2 to prepare compound 34 (white solid). The 1 H NMR and liquid quality data of compound 34 are as follows: 1 H NMR (600MHz, DMSO-d 6 ) δ 8.20 (s, 1H), 8.09 (d, 2H), 7.63 (d, 2H), 4.95 (s, 2H), 2.81(s, 6H).LC-MS(m/z,ESI): 389.2(MH).
实施例10:化合物35的制备Example 10: Preparation of Compound 35
Figure PCTCN2021093237-appb-000040
Figure PCTCN2021093237-appb-000040
将1g(3.58mmol)(4-(5-(三氟甲基)-1,2,4-噁二唑-3-基)苯基)甲胺盐酸盐放入50ml单口瓶中,加入20ml二氯甲烷并摇匀至充分混合,加入0.37g(3.66mmol)三乙胺,0.61g(3.59mmol)2-(双(甲硫基)亚甲基)丙二腈(参照Organic Process Research&Development,15(3),556-564;2011报道的方法制得),室温下搅拌反应。TLC监测反应完毕后,减压脱溶,残余物柱层析后得目标产物黄色固体1.09g。化合物35的 1H NMR数据如下: Put 1g (3.58mmol) (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)methylamine hydrochloride into a 50ml single-necked flask, add 20ml Dichloromethane and shake until well mixed, add 0.37g (3.66mmol) triethylamine, 0.61g (3.59mmol) 2-(bis(methylthio)methylene)malononitrile (refer to Organic Process Research&Development, 15 (3), 556-564; prepared by the method reported in 2011), the reaction was stirred at room temperature. After the reaction was monitored by TLC, the solvent was removed under reduced pressure, and the residue was subjected to column chromatography to obtain 1.09 g of the target product as a yellow solid. The 1 H NMR data of compound 35 are as follows:
1H NMR(600MHz,DMSO-d 6)δ9.31(s,1H),8.09(d,2H),7.56(d,2H),4.84(s,2H),2.63(s,3H). 1 H NMR (600MHz, DMSO-d 6 ) δ9.31 (s, 1H), 8.09 (d, 2H), 7.56 (d, 2H), 4.84 (s, 2H), 2.63 (s, 3H).
实施例11:化合物50的制备Example 11: Preparation of Compound 50
Figure PCTCN2021093237-appb-000041
Figure PCTCN2021093237-appb-000041
参照实施例7的合成方法制得化合物50(黄色油状物)。化合物50的 1H NMR及液质数据如下: According to the synthesis method of Example 7, compound 50 (yellow oil) was prepared. The 1 H NMR and liquid quality data of compound 50 are as follows:
1H NMR(600MHz,DMSO-d 6)δ8.06(d,2H),7.62(d,2H),4.97(s,2H),2.57(s,3H),2.03–1.95(m,1H),1.03–0.94(m,4H).LC-MS(m/z,ESI):434.1(M+H). 1 H NMR(600MHz,DMSO-d 6 )δ8.06(d,2H), 7.62(d,2H), 4.97(s,2H), 2.57(s,3H), 2.03-1.95(m,1H), 1.03-0.94(m,4H).LC-MS(m/z,ESI): 434.1(M+H).
实施例12:化合物53的制备Example 12: Preparation of Compound 53
Figure PCTCN2021093237-appb-000042
Figure PCTCN2021093237-appb-000042
参照实施例7的合成方法制得化合物53(黄色油状物)。化合物53的 1H NMR及液质数据如下: According to the synthesis method of Example 7, compound 53 (yellow oil) was prepared. The 1 H NMR and liquid quality data of compound 53 are as follows:
1H NMR(600MHz,DMSO-d 6)δ8.07(d,2H),7.64(d,2H),4.94(s,2H),2.53(s,3H),2.48(d,2H),1.09–1.00(m,1H),0.54–0.46(m,2H),0.22–0.16(m,2H).LC-MS(m/z,ESI):448.2(M+H). 1 H NMR(600MHz,DMSO-d 6 )δ8.07(d,2H), 7.64(d,2H), 4.94(s,2H), 2.53(s,3H), 2.48(d,2H), 1.09-- 1.00(m,1H),0.54-0.46(m,2H),0.22-0.16(m,2H).LC-MS(m/z,ESI): 448.2(M+H).
实施例13:化合物56的制备Example 13: Preparation of Compound 56
Figure PCTCN2021093237-appb-000043
Figure PCTCN2021093237-appb-000043
参照实施例7的合成方法制得化合物56(黄色油状物)。化合物56的 1H NMR及液质数据如下: According to the synthesis method of Example 7, compound 56 (yellow oil) was prepared. The 1 H NMR and liquid quality data of compound 56 are as follows:
1H NMR(600MHz,DMSO-d 6)δ8.07(d,2H),7.64(d,2H),4.93(s,2H),4.30(s,2H),3.34(s,3H),2.56(s,3H).LC-MS(m/z,ESI):438.1(M+H). 1 H NMR(600MHz,DMSO-d 6 )δ8.07(d,2H), 7.64(d,2H), 4.93(s,2H), 4.30(s,2H), 3.34(s,3H), 2.56( s,3H).LC-MS(m/z,ESI): 438.1(M+H).
实施例14:化合物69的制备Example 14: Preparation of Compound 69
(1)中间体2-(1-甲氧基亚乙基)丙二腈的合成(1) Synthesis of intermediate 2-(1-methoxyethylene)malononitrile
Figure PCTCN2021093237-appb-000044
Figure PCTCN2021093237-appb-000044
将1g(0.015mol)丙二腈放入50ml单口瓶中,加入1.91g(0.016mol)原乙酸三甲酯,升温至95℃搅拌反应,1.5小时后,停止反应。冷却至室温,减压脱溶后直接用于下步反应。Put 1g (0.015mol) of malononitrile into a 50ml single-necked flask, add 1.91g (0.016mol) of trimethyl orthoacetate, raise the temperature to 95°C and stir the reaction, and stop the reaction after 1.5 hours. After cooling to room temperature, it was directly used in the next reaction after desolving under reduced pressure.
(2)化合物69的合成(2) Synthesis of compound 69
Figure PCTCN2021093237-appb-000045
Figure PCTCN2021093237-appb-000045
50ml单口瓶中依次加入1g(3.58mmol)(4-(5-(三氟甲基)-1,2,4-噁二唑-3-基)苯基)甲胺盐酸盐、30ml乙醇及0.44g(4.36mmol)三乙胺,加入上步制备的2-(1-甲氧基亚乙基)丙二腈(0.52g,4.26mmol),升温40℃搅拌反应。TLC监测反应完毕后,减压脱溶,残余物柱层析后得目标产物白色固体0.97g。化合物69的 1H NMR及液质数据如下: Add 1g (3.58mmol) (4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)methylamine hydrochloride, 30ml ethanol and 0.44g (4.36mmol) of triethylamine was added to the 2-(1-methoxyethylene)malononitrile (0.52g, 4.26mmol) prepared in the previous step, and the reaction was stirred at a temperature of 40°C. After the reaction was monitored by TLC, the solvent was removed under reduced pressure, and the residue was column chromatographed to obtain 0.97 g of the target product as a white solid. The 1 H NMR and liquid quality data of compound 69 are as follows:
1H NMR(600MHz,Chloroform-d)δ8.18(d,2H),7.41(d,2H),6.92(s,1H),4.61(d,2H),2.28(s,3H).LC-MS(m/z,ESI):332.1(M-H). 1 H NMR (600MHz, Chloroform-d) δ 8.18 (d, 2H), 7.41 (d, 2H), 6.92 (s, 1H), 4.61 (d, 2H), 2.28 (s, 3H).LC-MS (m/z, ESI): 332.1(MH).
实施例15:化合物103的制备Example 15: Preparation of Compound 103
Figure PCTCN2021093237-appb-000046
Figure PCTCN2021093237-appb-000046
25ml单口瓶中加入0.1g(0.27mmol)2-((甲硫基)((4-(5-(三氟甲基)-1,2,4-噁二唑-3- 基)苄基)氨基)亚甲基)丙二腈、15ml乙醇、0.4g(2.86mmol)氨水(25%溶液),升温回流反应。TLC监测反应完毕后,减压脱溶,残余物柱层析后得目标产物白色固体0.07g。化合物103的 1H NMR及液质数据如下: Add 0.1g (0.27mmol) 2-((methylthio)((4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl) into a 25ml single-mouth bottle Amino)methylene)malononitrile, 15ml of ethanol, 0.4g (2.86mmol) of ammonia (25% solution), heated and refluxed for reaction. After the reaction was monitored by TLC, the solvent was removed under reduced pressure, and the residue was subjected to column chromatography to obtain 0.07 g of the target product as a white solid. The 1 H NMR and liquid quality data of compound 103 are as follows:
1H NMR(600MHz,Chloroform-d)δ8.20(d,2H),7.48(d,2H),6.03(s,1H),5.15(br s,2H),4.57(d,2H).LC-MS(m/z,ESI):333.2(M-H). 1 H NMR (600MHz, Chloroform-d) δ 8.20 (d, 2H), 7.48 (d, 2H), 6.03 (s, 1H), 5.15 (br s, 2H), 4.57 (d, 2H).LC- MS(m/z, ESI): 333.2(MH).
实施例16:化合物137的制备Example 16: Preparation of Compound 137
Figure PCTCN2021093237-appb-000047
Figure PCTCN2021093237-appb-000047
加入0.5g(2.18mmol)4-(5-(三氟甲基)-1,2,4-噁二唑-3-基)苯胺、0.32g(2.62mmol)乙氧基亚甲基丙二腈(参照WO2018005192报道的方法制得)及20ml乙醇,升温回流搅拌反应。TLC监测反应完毕后,减压脱溶,残余物柱层析后得目标产物白色固体0.12g。化合物137的 1H NMR数据如下: Add 0.5g (2.18mmol) 4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)aniline, 0.32g (2.62mmol) ethoxymethylenemalononitrile (Prepared with reference to the method reported in WO2018005192) and 20ml of ethanol, heated and refluxed and stirred for reaction. After the reaction was monitored by TLC, the solvent was removed under reduced pressure, and the residue was column chromatographed to obtain 0.12 g of the target product as a white solid. The 1 H NMR data of compound 137 are as follows:
1H NMR(600MHz,DMSO-d 6)δ10.58(s,1H),8.37(d,1H),8.03(d,2H),7.82(d,2H). 1 H NMR (600MHz, DMSO-d 6 ) δ 10.58 (s, 1H), 8.37 (d, 1H), 8.03 (d, 2H), 7.82 (d, 2H).
实施例17:化合物171的制备Example 17: Preparation of Compound 171
Figure PCTCN2021093237-appb-000048
Figure PCTCN2021093237-appb-000048
加入0.1g(0.44mmol)4-(5-(三氟甲基)-1,2,4-噁二唑-3-基)苯胺、0.11g(0.65mmol)2-(双(甲硫基)亚甲基)丙二腈及15ml乙醇,升温回流反应。TLC监测反应完毕后,减压脱溶,残余物柱层析后得目标产物黄色油状物0.12g。化合物171的 1H NMR数据如下: Add 0.1g (0.44mmol) 4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)aniline, 0.11g (0.65mmol) 2-(bis(methylthio) Methylene) malononitrile and 15 ml of ethanol are heated and refluxed for reaction. After the reaction was monitored by TLC, the solvent was removed under reduced pressure, and 0.12 g of the target yellow oily substance was obtained after column chromatography of the residue. The 1 H NMR data of compound 171 are as follows:
1H NMR(600MHz,DMSO-d 6)δ10.80(s,1H),8.11(d,2H),7.52(d,2H),2.57(s,3H). 1 H NMR (600MHz, DMSO-d 6 ) δ 10.80 (s, 1H), 8.11 (d, 2H), 7.52 (d, 2H), 2.57 (s, 3H).
生物活性测定Biological activity determination
实施例18:对植物细菌病害防治效果的测定Example 18: Determination of the control effect on plant bacterial diseases
用本发明的化合物对多种植物细菌性病害进行了防效测定,针对不同的细菌性病害,试验程序如下:The compound of the present invention has been used for the prevention and control of various plant bacterial diseases. For different bacterial diseases, the test procedure is as follows:
甜瓜果斑病:将待测化合物用少量N,N二甲基甲酰胺溶解,用水稀释至所需要的浓度。将培养至稳定生长期的病原细菌与定量化合物溶液混合均匀,将经过催芽的甜瓜种子放入菌液与化合物的混合液中浸泡半小时,再将种子播种于蚯蚓土培养杯中,放入温室中保湿培养,一般培养两周时间,待对照充分发病后进行防效调查。Melon fruit spot disease: Dissolve the test compound with a small amount of N,N dimethylformamide and dilute with water to the required concentration. The pathogenic bacteria cultivated to the stable growth stage are mixed with the quantitative compound solution uniformly, the melon seeds that have been germinated are soaked in the mixture of the bacterial solution and the compound for half an hour, and then the seeds are sown in the earthworm soil culture cup and placed in the greenhouse Medium moisturizing culture, usually culture for two weeks, after the control has fully developed the disease, the control effect investigation will be carried out.
大白菜软腐病:切取2厘米见方的白菜叶片,放入垫有双层滤纸的玻璃培养皿中。将用N,N二甲基甲酰胺溶解,并用水稀释至所需浓度的化合物喷雾于白菜叶片表面,于通风橱内晾干白菜叶片表面药液后,使用接种针在白菜叶片表面针刺造成伤口,将培养至稳定生长期的大白菜软腐病菌取5微升加入伤口内,进行接种。最后将试材放入培养箱中避光培养48小时,待对照充分发病后进行防效调查。Chinese cabbage soft rot: Cut 2 cm square cabbage leaves and put them in a glass petri dish lined with double-layer filter paper. The compound dissolved in N,N dimethylformamide and diluted with water to the required concentration is sprayed on the surface of the cabbage leaves. After drying the liquid on the surface of the cabbage leaves in a fume hood, the inoculation needle is used to acupuncture the surface of the cabbage leaves. For the wound, 5 microliters of soft rot fungus of Chinese cabbage cultivated to a stable growth period is added to the wound for inoculation. Finally, the test materials were placed in an incubator for 48 hours in the dark, and the control effect was investigated after the control had fully developed disease.
黄瓜细菌性角斑病、番茄细菌性叶斑病、水稻细菌性条斑病、水稻白叶枯病:将待测化合物用少量N,N二甲基甲酰胺溶解,用水稀释至所需要的浓度。将化合物其喷雾于植物试材表面,于阴凉处风干表面药液后,将培养至稳定生长期的病原细菌菌液喷雾接种于植物试材表面,然后将植物试材放入温室中保湿培养。通常培养十天左右,待对照充分发病后,进行防效调查。Cucumber bacterial angular leaf spot, tomato bacterial leaf spot, rice bacterial leaf spot, rice bacterial leaf blight: dissolve the test compound with a small amount of N,N dimethylformamide and dilute with water to the required concentration . The compound is sprayed on the surface of the plant test material, and after the surface drug solution is air-dried in a cool place, the pathogenic bacteria liquid cultured to a stable growth stage is sprayed on the surface of the plant test material, and then the plant test material is placed in a greenhouse for moisturizing culture. It is usually cultivated for about ten days, and after the control has fully developed the disease, the control effect investigation will be carried out.
柑桔溃疡病:试验设处理和对照,每个处理10次重复,每个重复1张叶片,使用接种针在柑橘离体叶片上造成8-10个针刺点;用无菌水将药剂原液(即将待测化合物用少量N,N二甲基甲酰胺溶解)稀释至所需浓度后对柑橘离体叶片进行叶面喷施,再接种病原菌,处理完成后置于90mm培养皿中(用适量无菌水润湿吸水纸,置于培养皿底部进行保湿),于28℃恒温箱内培养,7天后观察并记录柑橘溃疡病的离体发病情况,进行防效调查。防治效果(%)=(对照针刺发病点数-处理针刺发病点数)/对照针刺发病点数×100%。Citrus canker disease: The experiment was set up with treatments and controls. Each treatment was repeated 10 times, and each repeated 1 leaf. The inoculation needle was used to create 8-10 acupuncture points on the detached citrus leaf; (I.e., dissolve the test compound with a small amount of N,N dimethylformamide) after diluting to the required concentration, apply foliar spray to the detached citrus leaves, and then inoculate the pathogenic bacteria. After the treatment is completed, place it in a 90mm petri dish (use an appropriate amount) Sterile water-moistened absorbent paper, placed on the bottom of the petri dish for moisturizing), cultured in a thermostat at 28°C, 7 days later, observed and recorded the in vitro incidence of citrus canker, and investigated the prevention effect. Control effect (%)=(control acupuncture incidence points-treatment acupuncture incidence points)/control acupuncture incidence points×100%.
测试结果如下:The test results are as follows:
600mg/L时,化合物1、12、13、14、15、16、19、22、34、35、50、53、56、69、103、137、171对甜瓜果斑病的防效不低于90%。At 600mg/L, compounds 1, 12, 13, 14, 15, 16, 19, 22, 34, 35, 50, 53, 56, 69, 103, 137, and 171 are not ineffective against melon fruit spot disease Less than 90%.
400mg/L时,化合物1、12、13、14、15、16、19、22、34、35、50、53、56、69、103、137、171对黄瓜细菌性角斑病、水稻细菌性条斑病、水稻白叶枯病、大白菜软腐病和番茄细菌性叶斑病的防效不低于90%。At 400 mg/L, compounds 1, 12, 13, 14, 15, 16, 19, 22, 34, 35, 50, 53, 56, 69, 103, 137, and 171 have an effect on cucumber bacterial angular leaf spot and rice bacterial The control effect of leaf spot, rice bacterial leaf blight, soft rot of Chinese cabbage and tomato bacterial leaf spot is not less than 90%.
100mg/L时,化合物1、12、13、14、15、16、19、22、34、35、50、53、56、69、103、137、171对柑橘溃疡病的防效不低于90%。At 100mg/L, compound 1, 12, 13, 14, 15, 16, 19, 22, 34, 35, 50, 53, 56, 69, 103, 137, and 171 have no less than 90 preventive effects against citrus canker. %.
实施例19:对大豆锈病的杀菌活性测定Example 19: Determination of bactericidal activity against soybean rust
保护活性测试方法:采用活体盆栽测定方法,即将待测化合物样品用少量溶剂(溶剂的种类如丙酮、甲醇、DMF等,并且依据其对样品的溶解能力而选择,溶剂量与喷液量的体积比等于或小于0.05)溶解,用含有0.1%吐温80的水稀释,配制成所需浓度待测液,另设溶剂清水液作为空白对照。在作物喷雾机上,将待测液喷施于病害寄主植物上(寄主植物为在温室内培养的标准盆栽苗),24小时后进行病害接种。依据病害特点,将需要控温保湿培养的病害植物接种后放在人工气候室中培养,待病害完成侵染后,移入温室培养;将不需要保湿培 养的病害植物直接在温室内接种并培养。待对照充分发病后(通常为一周时间)进行化合物防病效果评估。Protective activity test method: The method of in vivo potting is adopted, that is, a small amount of solvent is used for the sample of the compound to be tested (the type of solvent is acetone, methanol, DMF, etc., and it is selected according to its ability to dissolve the sample. The volume of the solvent and the spray volume The ratio is equal to or less than 0.05) to dissolve, dilute with water containing 0.1% Tween 80 to prepare the test solution of the required concentration, and set a solvent clear water solution as a blank control. On a crop sprayer, spray the test solution on the diseased host plants (the host plants are standard potted seedlings cultivated in the greenhouse), and then inoculate the disease 24 hours later. According to the characteristics of the disease, the diseased plants that need temperature control and moisturizing culture are inoculated and cultured in an artificial climate room. After the disease is infested, they are moved to the greenhouse for cultivation; the diseased plants that do not need moisturizing culture are directly inoculated and cultivated in the greenhouse. After the control is fully onset (usually one week), the compound's disease prevention effect will be evaluated.
对大豆锈病的活体保护活性如下:The in vivo protective activities against soybean rust are as follows:
药液浓度为100毫克/升时,化合物1、12、13、14、15、16、19、22、34、35、50、53、56、69、103、137、171对大豆锈病的防效不低于90%;When the concentration of the drug solution is 100 mg/L, the effects of compounds 1, 12, 13, 14, 15, 16, 19, 22, 34, 35, 50, 53, 56, 69, 103, 137, and 171 on soybean rust Not less than 90%;
药液浓度为25毫克/升时,化合物1、12、13、14、15、16、19、22、34、35、50、56、69、103、171对大豆锈病的防效不低于90%;When the concentration of the drug solution is 25 mg/L, the control effect of compound 1, 12, 13, 14, 15, 16, 19, 22, 34, 35, 50, 56, 69, 103, 171 against soybean rust is not less than 90 %;
药液浓度为6.25毫克/升时,化合物1、12、13、14、16、22、34、35、50、56、69对大豆锈病的防效不低于90%;When the concentration of the drug solution is 6.25 mg/L, the control effect of compounds 1, 12, 13, 14, 16, 22, 34, 35, 50, 56, 69 on soybean rust is not less than 90%;
药液浓度为3.125毫克/升时,化合物1、16、22、34对大豆锈病的防效不低于90%;When the concentration of the liquid medicine is 3.125 mg/L, the control effect of compound 1, 16, 22, 34 on soybean rust is not less than 90%;
药液浓度为0.39毫克/升时,化合物16、22对大豆锈病的防效不低于90%。When the concentration of the drug solution is 0.39 mg/L, the control effect of compounds 16 and 22 on soybean rust is not less than 90%.

Claims (13)

  1. 一种噁二唑类化合物,其特征在于:化合物如通式I所示:An oxadiazole compound, characterized in that: the compound is represented by general formula I:
    Figure PCTCN2021093237-appb-100001
    Figure PCTCN2021093237-appb-100001
    式中:Where:
    R 1选自氢、羟基、巯基、氨基、氰基、C 1-C 6烷基、卤代C 1-C 6烷基、C 1-C 6烷氧基、卤代C 1-C 6烷氧基、C 1-C 6烷硫基、卤代C 1-C 6烷硫基、C 1-C 6烷基氨基或C 1-C 6二烷基氨基; R 1 is selected from hydrogen, hydroxyl, mercapto, amino, cyano, C 1 -C 6 alkyl, halogenated C 1 -C 6 alkyl, C 1 -C 6 alkoxy, halogenated C 1 -C 6 alkane Oxy, C 1 -C 6 alkylthio, halogenated C 1 -C 6 alkylthio, C 1 -C 6 alkylamino or C 1 -C 6 dialkylamino;
    R 2选自氢、C 1-C 6烷基、卤代C 1-C 6烷基、C 1-C 6烷基羰基、C 3-C 6环烷基羰基、C 3-C 6环烷基C 1-C 3烷基羰基、C 1-C 6烷氧基羰基、C 1-C 6烷氧基C 1-C 3烷基羰基、C 1-C 6烷硫基C 1-C 3烷基羰基、C 1-C 6烷基氨基羰基或C 1-C 6二烷基氨基羰基; R 2 is selected from hydrogen, C 1 -C 6 alkyl, halogenated C 1 -C 6 alkyl, C 1 -C 6 alkylcarbonyl, C 3 -C 6 cycloalkylcarbonyl, C 3 -C 6 cycloalkane C 1 -C 3 alkylcarbonyl, C 1 -C 6 alkoxycarbonyl, C 1 -C 6 alkoxy C 1 -C 3 alkylcarbonyl, C 1 -C 6 alkylthio C 1 -C 3 Alkylcarbonyl, C 1 -C 6 alkylaminocarbonyl or C 1 -C 6 dialkylaminocarbonyl;
    X 1、X 2各自独立地选自氢、卤素或C 1-C 6烷基; X 1 and X 2 are each independently selected from hydrogen, halogen or C 1 -C 6 alkyl;
    n选自0或1;n is selected from 0 or 1;
    或通式I化合物的盐。Or a salt of a compound of general formula I.
  2. 根据权利要求1所述的化合物,其特征在于:通式I中The compound according to claim 1, characterized in that: in the general formula I
    R 1选自氢、羟基、巯基、氨基、氰基、C 1-C 3烷基、卤代C 1-C 3烷基、C 1-C 3烷氧基、卤代C 1-C 3烷氧基、C 1-C 3烷硫基、卤代C 1-C 3烷硫基、C 1-C 3烷基氨基或C 1-C 3二烷基氨基; R 1 is selected from hydrogen, hydroxyl, mercapto, amino, cyano, C 1 -C 3 alkyl, halo C 1 -C 3 alkyl, C 1 -C 3 alkoxy, halo C 1 -C 3 alkane Oxy, C 1 -C 3 alkylthio, halogenated C 1 -C 3 alkylthio, C 1 -C 3 alkylamino or C 1 -C 3 dialkylamino;
    R 2选自氢、C 1-C 4烷基、卤代C 1-C 4烷基、C 1-C 4烷基羰基、C 3-C 4环烷基羰基、C 3-C 4环烷基C 1-C 2烷基羰基、C 1-C 4烷氧基羰基、C 1-C 4烷氧基C 1-C 2烷基羰基、C 1-C 4烷硫基C 1-C 2烷基羰基、C 1-C 4烷基氨基羰基或C 1-C 4二烷基氨基羰基; R 2 is selected from hydrogen, C 1 -C 4 alkyl, halogenated C 1 -C 4 alkyl, C 1 -C 4 alkylcarbonyl, C 3 -C 4 cycloalkylcarbonyl, C 3 -C 4 cycloalkane C 1 -C 2 alkylcarbonyl, C 1 -C 4 alkoxycarbonyl, C 1 -C 4 alkoxy C 1 -C 2 alkylcarbonyl, C 1 -C 4 alkylthio C 1 -C 2 Alkylcarbonyl, C 1 -C 4 alkylaminocarbonyl or C 1 -C 4 dialkylaminocarbonyl;
    X 1、X 2各自独立地选自氢、氟或甲基; X 1 and X 2 are each independently selected from hydrogen, fluorine or methyl;
    n选自0或1;n is selected from 0 or 1;
    或通式I化合物与盐酸、氢溴酸、硫酸、磷酸、甲酸、乙酸、丙酸、丁酸、戊酸、三氟乙酸、草酸、丙二酸、甲磺酸、4-甲苯磺酸、苹果酸、富马酸、乳酸、马来酸、水杨酸、酒石酸或柠檬酸形成的盐。Or compound of general formula I and hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, formic acid, acetic acid, propionic acid, butyric acid, valeric acid, trifluoroacetic acid, oxalic acid, malonic acid, methanesulfonic acid, 4-toluenesulfonic acid, apple Salts of acid, fumaric acid, lactic acid, maleic acid, salicylic acid, tartaric acid or citric acid.
  3. 根据权利要求2所述的化合物,其特征在于:通式I中The compound according to claim 2, characterized in that: in the general formula I
    R 1选自氢、羟基、巯基、氨基、氰基、C 1-C 3烷基、卤代C 1-C 3烷基、C 1-C 3烷氧基、卤代C 1-C 3烷氧基、C 1-C 3烷硫基、卤代C 1-C 3烷硫基、C 1-C 3烷基氨基或C 1-C 3 二烷基氨基; R 1 is selected from hydrogen, hydroxyl, mercapto, amino, cyano, C 1 -C 3 alkyl, halo C 1 -C 3 alkyl, C 1 -C 3 alkoxy, halo C 1 -C 3 alkane Oxy, C 1 -C 3 alkylthio, halogenated C 1 -C 3 alkylthio, C 1 -C 3 alkylamino or C 1 -C 3 dialkylamino;
    R 2选自氢、C 1-C 4烷基、卤代C 1-C 4烷基、C 1-C 4烷基羰基、C 3-C 4环烷基羰基、2-(C 3-C 4环烷基)乙酰基、C 1-C 4烷氧基羰基、2-(C 1-C 4烷氧基)乙酰基、2-(C 1-C 4烷硫基)乙酰基、C 1-C 4烷基氨基羰基或C 1-C 4二烷基氨基羰基; R 2 is selected from hydrogen, C 1 -C 4 alkyl, halogenated C 1 -C 4 alkyl, C 1 -C 4 alkylcarbonyl, C 3 -C 4 cycloalkylcarbonyl, 2-(C 3 -C 4 cycloalkyl) acetyl, C 1 -C 4 alkoxycarbonyl, 2-(C 1 -C 4 alkoxy)acetyl, 2-(C 1 -C 4 alkylthio)acetyl, C 1 -C 4 alkylaminocarbonyl or C 1 -C 4 dialkylaminocarbonyl;
    X 1、X 2选自氢、氟或甲基; X 1 and X 2 are selected from hydrogen, fluorine or methyl;
    n选自0或1;n is selected from 0 or 1;
    或通式I化合物与盐酸、氢溴酸、硫酸、磷酸、甲酸、乙酸、丙酸、丁酸、戊酸、三氟乙酸、草酸、丙二酸、甲磺酸、4-甲苯磺酸、苹果酸、富马酸、乳酸、马来酸、水杨酸、酒石酸或柠檬酸形成的盐。Or compound of general formula I and hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, formic acid, acetic acid, propionic acid, butyric acid, valeric acid, trifluoroacetic acid, oxalic acid, malonic acid, methanesulfonic acid, 4-toluenesulfonic acid, apple Salts of acid, fumaric acid, lactic acid, maleic acid, salicylic acid, tartaric acid or citric acid.
  4. 根据权利要求3所述的化合物,其特征在于:通式I中The compound according to claim 3, characterized in that: in the general formula I
    R 1选自氢、氨基、C 1-C 3烷基、C 1-C 3烷氧基或C 1-C 3烷硫基; R 1 is selected from hydrogen, amino, C 1 -C 3 alkyl, C 1 -C 3 alkoxy or C 1 -C 3 alkylthio;
    R 2选自氢、C 1-C 4烷基、卤代C 1-C 4烷基、C 1-C 4烷基羰基、C 3-C 4环烷基羰基、2-(C 3-C 4环烷基)乙酰基、2-(C 1-C 4烷氧基)乙酰基或C 1-C 4二烷基氨基羰基; R 2 is selected from hydrogen, C 1 -C 4 alkyl, halogenated C 1 -C 4 alkyl, C 1 -C 4 alkylcarbonyl, C 3 -C 4 cycloalkylcarbonyl, 2-(C 3 -C 4 -cycloalkyl)acetyl, 2-(C 1 -C 4 alkoxy)acetyl or C 1 -C 4 dialkylaminocarbonyl;
    X 1、X 2选自氢; X 1 and X 2 are selected from hydrogen;
    n选自0或1;n is selected from 0 or 1;
    或通式I化合物与盐酸、氢溴酸、硫酸、磷酸、甲酸、乙酸、丙酸、丁酸、戊酸、三氟乙酸、草酸、丙二酸、甲磺酸、4-甲苯磺酸、苹果酸、富马酸、乳酸、马来酸、水杨酸、酒石酸或柠檬酸形成的盐。Or compound of general formula I and hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, formic acid, acetic acid, propionic acid, butyric acid, valeric acid, trifluoroacetic acid, oxalic acid, malonic acid, methanesulfonic acid, 4-toluenesulfonic acid, apple Salts of acid, fumaric acid, lactic acid, maleic acid, salicylic acid, tartaric acid or citric acid.
  5. 根据权利要求4所述的化合物,其特征在于:通式I中The compound according to claim 4, characterized in that: in the general formula I
    R 1选自氢; R 1 is selected from hydrogen;
    R 2选自氢、C 1-C 4烷基、卤代C 1-C 4烷基、C 1-C 4烷基羰基、C 3-C 4环烷基羰基、2-(C 3-C 4环烷基)乙酰基、2-(C 1-C 4烷氧基)乙酰基或C 1-C 4二烷基氨基羰基; R 2 is selected from hydrogen, C 1 -C 4 alkyl, halogenated C 1 -C 4 alkyl, C 1 -C 4 alkylcarbonyl, C 3 -C 4 cycloalkylcarbonyl, 2-(C 3 -C 4 -cycloalkyl)acetyl, 2-(C 1 -C 4 alkoxy)acetyl or C 1 -C 4 dialkylaminocarbonyl;
    X 1、X 2选自氢; X 1 and X 2 are selected from hydrogen;
    n选自0或1;n is selected from 0 or 1;
    或通式I化合物与盐酸、氢溴酸、硫酸、磷酸、甲酸、乙酸、丙酸、丁酸、戊酸、三氟乙酸、草酸、丙二酸、甲磺酸、4-甲苯磺酸、苹果酸、富马酸、乳酸、马来酸、水杨酸、酒石酸或柠檬酸形成的盐。Or compound of general formula I and hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, formic acid, acetic acid, propionic acid, butyric acid, valeric acid, trifluoroacetic acid, oxalic acid, malonic acid, methanesulfonic acid, 4-toluenesulfonic acid, apple Salts of acid, fumaric acid, lactic acid, maleic acid, salicylic acid, tartaric acid or citric acid.
  6. 根据权利要求5所述的化合物,其特征在于:通式I中The compound according to claim 5, characterized in that: in the general formula I
    R 1选自氢; R 1 is selected from hydrogen;
    R 2选自氢、C 1-C 4烷基、卤代C 1-C 4烷基、C 1-C 4烷基羰基、C 3-C 4环烷基羰基、2-(C 3-C 4环烷基)乙酰基、2-(C 1-C 4烷氧基)乙酰基或C 1-C 4二烷基氨基羰基; R 2 is selected from hydrogen, C 1 -C 4 alkyl, halogenated C 1 -C 4 alkyl, C 1 -C 4 alkylcarbonyl, C 3 -C 4 cycloalkylcarbonyl, 2-(C 3 -C 4 -cycloalkyl)acetyl, 2-(C 1 -C 4 alkoxy)acetyl or C 1 -C 4 dialkylaminocarbonyl;
    X 1、X 2选自氢; X 1 and X 2 are selected from hydrogen;
    n选自0;n is selected from 0;
    或通式I化合物与盐酸、氢溴酸、硫酸、磷酸、甲酸、乙酸、丙酸、丁酸、戊酸、三氟乙酸、草酸、丙二酸、甲磺酸、4-甲苯磺酸、苹果酸、富马酸、乳酸、马来酸、水杨酸、酒石酸或柠檬酸形成的盐。Or compound of general formula I and hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, formic acid, acetic acid, propionic acid, butyric acid, valeric acid, trifluoroacetic acid, oxalic acid, malonic acid, methanesulfonic acid, 4-toluenesulfonic acid, apple Salts of acid, fumaric acid, lactic acid, maleic acid, salicylic acid, tartaric acid or citric acid.
  7. 根据权利要求4所述的化合物,其特征在于:通式I中The compound according to claim 4, characterized in that: in the general formula I
    R 1选自氢、氨基、C 1-C 3烷基或C 1-C 3烷硫基; R 1 is selected from hydrogen, amino, C 1 -C 3 alkyl or C 1 -C 3 alkylthio;
    R 2选自氢、C 1-C 4烷基、卤代C 1-C 4烷基、C 1-C 4烷基羰基、C 3-C 4环烷基羰基、2-(C 3-C 4环烷基)乙酰基、2-(C 1-C 4烷氧基)乙酰基或C 1-C 4二烷基氨基羰基; R 2 is selected from hydrogen, C 1 -C 4 alkyl, halogenated C 1 -C 4 alkyl, C 1 -C 4 alkylcarbonyl, C 3 -C 4 cycloalkylcarbonyl, 2-(C 3 -C 4 -cycloalkyl)acetyl, 2-(C 1 -C 4 alkoxy)acetyl or C 1 -C 4 dialkylaminocarbonyl;
    X 1、X 2选自氢; X 1 and X 2 are selected from hydrogen;
    n选自1;n is selected from 1;
    或通式I化合物与盐酸、氢溴酸、硫酸、磷酸、甲酸、乙酸、丙酸、丁酸、戊酸、三氟乙酸、草酸、丙二酸、甲磺酸、4-甲苯磺酸、苹果酸、富马酸、乳酸、马来酸、水杨酸、酒石酸或柠檬酸形成的盐。Or compound of general formula I and hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, formic acid, acetic acid, propionic acid, butyric acid, valeric acid, trifluoroacetic acid, oxalic acid, malonic acid, methanesulfonic acid, 4-toluenesulfonic acid, apple Salts of acid, fumaric acid, lactic acid, maleic acid, salicylic acid, tartaric acid or citric acid.
  8. 根据权利要求3所述的化合物,其特征在于:通式I中The compound according to claim 3, characterized in that: in the general formula I
    R 1选自氢、羟基、巯基、氨基、氰基、甲基、乙基、正丙基、异丙基、三氟甲基、甲氧基、乙氧基、二氟甲氧基、三氟甲氧基、甲硫基、乙硫基、三氟乙硫基、甲氨基、乙氨基或N,N-二甲基氨基; R 1 is selected from hydrogen, hydroxyl, mercapto, amino, cyano, methyl, ethyl, n-propyl, isopropyl, trifluoromethyl, methoxy, ethoxy, difluoromethoxy, trifluoro Methoxy, methylthio, ethylthio, trifluoroethylthio, methylamino, ethylamino or N,N-dimethylamino;
    R 2选自氢、甲基、乙基、正丙基、异丙基、正丁基、异丁基、仲丁基、叔丁基、三氟甲基、乙酰基、丙酰基、正丁酰基、异丁酰基、正戊酰基、环丙基羰基、1-氰基环丙基-1-羰基、环丁基羰基、2-环丙基乙酰基、甲氧基羰基、乙氧基羰基、2-甲氧基乙酰基、2-乙氧基乙酰基、2-正丙氧基乙酰基、2-异丙氧基乙酰基、2-正丁氧基乙酰基、2-仲丁氧基乙酰基、2-异丁氧基乙酰基、2-叔丁氧基乙酰基、2-甲硫基乙酰基、2-乙硫基乙酰基、N-甲基氨基羰基、N-乙基氨基羰基或N,N-二甲基氨基羰基; R 2 is selected from hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, trifluoromethyl, acetyl, propionyl, n-butyryl , Isobutyryl, n-valeryl, cyclopropylcarbonyl, 1-cyanocyclopropyl-1-carbonyl, cyclobutylcarbonyl, 2-cyclopropylacetyl, methoxycarbonyl, ethoxycarbonyl, 2 -Methoxyacetyl, 2-ethoxyacetyl, 2-n-propoxyacetyl, 2-isopropoxyacetyl, 2-n-butoxyacetyl, 2-sec-butoxyacetyl , 2-isobutoxyacetyl, 2-tert-butoxyacetyl, 2-methylthioacetyl, 2-ethylthioacetyl, N-methylaminocarbonyl, N-ethylaminocarbonyl or N ,N-Dimethylaminocarbonyl;
    X 1、X 2选自氢、氟或甲基; X 1 and X 2 are selected from hydrogen, fluorine or methyl;
    n选自0或1;n is selected from 0 or 1;
    或通式I化合物与盐酸、氢溴酸、硫酸、磷酸、甲酸、乙酸、丙酸、丁酸、戊酸、三氟乙酸、草酸、丙二酸、甲磺酸、4-甲苯磺酸、苹果酸、富马酸、乳酸、马来酸、水杨酸、酒石酸或柠檬酸形成的盐。Or compound of general formula I and hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, formic acid, acetic acid, propionic acid, butyric acid, valeric acid, trifluoroacetic acid, oxalic acid, malonic acid, methanesulfonic acid, 4-toluenesulfonic acid, apple Salts of acid, fumaric acid, lactic acid, maleic acid, salicylic acid, tartaric acid or citric acid.
  9. 一种按照权利要求1所述的通式I化合物在农业、林业或卫生领域中作为杀细菌剂的用途。A use of the compound of general formula I according to claim 1 as a bactericide in the fields of agriculture, forestry or sanitation.
  10. 根据权利要求9所述的通式I化合物用于控制植物细菌性病害的用途,其特征在于:所述植物细菌性病害为果斑病、叶斑病、青枯病、细菌性疫病、溃疡病、软腐病、细菌性角斑病、细菌性条斑病、叶枯病、白叶枯病、野火病或细菌性疮痂病。The use of the compound of general formula I according to claim 9 for controlling plant bacterial diseases, characterized in that: the plant bacterial diseases are fruit spot, leaf spot, bacterial wilt, bacterial blight, ulcer disease , Soft rot, bacterial angular leaf spot, bacterial leaf streak, leaf blight, bacterial leaf blight, wildfire or bacterial scab.
  11. 一种按照权利要求1所述的通式I化合物在农业、林业或卫生领域中作为杀真菌剂的用途。A use of the compound of general formula I according to claim 1 as a fungicide in the fields of agriculture, forestry or sanitation.
  12. 一种杀菌组合物,其特征在于:组合物中含有权利要求1所述的通式I化合物和农业上可接受的载体,组合物中活性组分的重量百分含量为0.1-99%。A bactericidal composition, characterized in that the composition contains the compound of general formula I according to claim 1 and an agriculturally acceptable carrier, and the weight percentage of the active component in the composition is 0.1-99%.
  13. 一种防治病菌的方法,其特征在于:向作物或作物的生长介质或地点上施用杀菌有效剂量的如权利要求12所述的杀菌组合物。A method for preventing and controlling pathogens, which is characterized in that: applying a bactericidal effective dose of the bactericidal composition according to claim 12 to the crop or the growth medium or location of the crop.
PCT/CN2021/093237 2020-06-01 2021-05-12 Oxadiazole compound and application thereof WO2021244244A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202010483605 2020-06-01
CN202010483605.6 2020-06-01

Publications (1)

Publication Number Publication Date
WO2021244244A1 true WO2021244244A1 (en) 2021-12-09

Family

ID=78787039

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2021/093237 WO2021244244A1 (en) 2020-06-01 2021-05-12 Oxadiazole compound and application thereof

Country Status (2)

Country Link
CN (1) CN113754607B (en)
WO (1) WO2021244244A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY39854A (en) * 2021-07-15 2022-11-30 Kumiai Chemical Industry Co FORMAMIDE DERIVATIVE AND HORTICULTURAL AND AGRICULTURAL CONTROL AGENT FOR THE CONTROL OF DISEASES OF THE

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57146705A (en) * 1981-03-09 1982-09-10 Hokkai Sankyo Kk Antibacterial for agricultural and horticultural purposes
CN109068652A (en) * 2016-04-08 2018-12-21 先正达参股股份有限公司 Kill the oxadiazole derivatives of microorganism
CN110054596A (en) * 2018-05-29 2019-07-26 沈阳化工大学 A kind of substitution furodiazole compound and its application

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57146705A (en) * 1981-03-09 1982-09-10 Hokkai Sankyo Kk Antibacterial for agricultural and horticultural purposes
CN109068652A (en) * 2016-04-08 2018-12-21 先正达参股股份有限公司 Kill the oxadiazole derivatives of microorganism
CN110054596A (en) * 2018-05-29 2019-07-26 沈阳化工大学 A kind of substitution furodiazole compound and its application

Also Published As

Publication number Publication date
CN113754607B (en) 2023-09-05
CN113754607A (en) 2021-12-07

Similar Documents

Publication Publication Date Title
EP0532022B1 (en) Acrylate compound, preparation process thereof and fungicide using the same
US7786040B2 (en) 4-cyclopropyl-1,2,3,-thiadiazole compound, agrohorticultural plant disease controlling agent and method of using the same
AU2008255459B2 (en) Substituted pyrimidine ether compounds and use thereof
PL175078B1 (en) Substituted pyrimidines and method of obtaining them
EP0888359A1 (en) Pyrimidin-4-one derivatives as pesticide
SK9142002A3 (en) N-(5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidin-2-yl) arylsulfonamide compounds and their use as herbicides
KR19980018703A (en) SUBSTITUTED CARBOXYLIC ACID ANILIDE DERIVATIVES AND PREVENTIVE AND EXTERMINATOR OF BLIGHT COMPRISING THE DERIVATIVE AS ACTIVE INGREDINET
JPH069313A (en) Rice blast controlling agent containing isothiazole carboxylic acid anilide derivative as active components
CN110054596B (en) Substituted oxadiazole compound and application thereof
KR20040004427A (en) N-([1,2,4]Triazoloazinyl) thiophenesulfonamide compounds as herbicides
OA10106A (en) (Hetero) -aryl-alkyl-cetoxim-o-ethers substituted insecticidal acaricides and nematocides process for their preparation agents containing them and their use as pest control agents
WO2021244244A1 (en) Oxadiazole compound and application thereof
JPH0737450B2 (en) Phenoxyalkylamine derivatives, insecticides, acaricides and fungicides
JP2817863B2 (en) Fluorine-containing pyrazole compound, its production method and pest control agent
CN113045561B (en) Diarylamine derivatives as fungicides
KR19980070796A (en) 1-phenyl-5-anilinotetrazole
US9018218B2 (en) Substituted pyrimidine ammonia compounds and uses thereof
JP3074658B2 (en) Aralkylaminopyrimidine derivatives, their preparation and pesticides
CN110963963A (en) Pyridine amide compound and sterilization application thereof
JP3211518B2 (en) Phenoxyalkylamine derivatives, their preparation and pesticides for agricultural and horticultural use
CN108976167B (en) Substituted phenylhydrazine compound and application thereof
TW486471B (en) Pyrimidin-2-oxy-4-one and pyrimidin-2-oxy-4-thione derivatives
JP2673848B2 (en) Alkylaminopyrimidine derivatives, their preparation and pesticides
CN108059623B (en) Substituted aryl-containing bisisoxazole aryl amidine compound, and preparation method and application thereof
JP2803075B2 (en) Phenoxyalkylamine compounds, their preparation and pest control agents

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21817602

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21817602

Country of ref document: EP

Kind code of ref document: A1